
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Hereditary Transthyretin-Related Amyloidosis Ongoing Observational Study: A Baseline Report of the First 3167 Participants - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="DB2B14CF9260A7333C14CF00145F646B.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="jclinmed">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11508262/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Journal of Clinical Medicine">
<meta name="citation_title" content="Hereditary Transthyretin-Related Amyloidosis Ongoing Observational Study: A Baseline Report of the First 3167 Participants">
<meta name="citation_author" content="Sabine Rösner">
<meta name="citation_author_institution" content="CENTOGENE GmbH, 18055 Rostock, Germany; sabine.roesner@centogene.com (S.R.); luba.pardo@centogene.com (L.M.P.); aida.bertoli-avella@centogene.com (A.M.B.-A.); skrahinavolha@gmail.com (V.S.); engel.pierre@gmail.com (P.E.); sabine.schroeder@centogene.com (S.S.); susan.zielske@centogene.com (S.Z.); valerie.bonke@centogene.com (V.B.); gina.westphal@centogene.com (G.W.); felix-reder@gmx.de (F.R.); snezanaskobalj@gmail.com (S.S.); susanne.zielke@mail.de (S.Z.); xenia_bogdanovic@web.de (X.B.); paula.grieger@uksh.de (P.G.); j-rennecke@t-online.de (J.R.); arndt.rolfs@web.de (A.R.)">
<meta name="citation_author" content="Luba M Pardo">
<meta name="citation_author_institution" content="CENTOGENE GmbH, 18055 Rostock, Germany; sabine.roesner@centogene.com (S.R.); luba.pardo@centogene.com (L.M.P.); aida.bertoli-avella@centogene.com (A.M.B.-A.); skrahinavolha@gmail.com (V.S.); engel.pierre@gmail.com (P.E.); sabine.schroeder@centogene.com (S.S.); susan.zielske@centogene.com (S.Z.); valerie.bonke@centogene.com (V.B.); gina.westphal@centogene.com (G.W.); felix-reder@gmx.de (F.R.); snezanaskobalj@gmail.com (S.S.); susanne.zielke@mail.de (S.Z.); xenia_bogdanovic@web.de (X.B.); paula.grieger@uksh.de (P.G.); j-rennecke@t-online.de (J.R.); arndt.rolfs@web.de (A.R.)">
<meta name="citation_author" content="Aida M Bertoli-Avella">
<meta name="citation_author_institution" content="CENTOGENE GmbH, 18055 Rostock, Germany; sabine.roesner@centogene.com (S.R.); luba.pardo@centogene.com (L.M.P.); aida.bertoli-avella@centogene.com (A.M.B.-A.); skrahinavolha@gmail.com (V.S.); engel.pierre@gmail.com (P.E.); sabine.schroeder@centogene.com (S.S.); susan.zielske@centogene.com (S.Z.); valerie.bonke@centogene.com (V.B.); gina.westphal@centogene.com (G.W.); felix-reder@gmx.de (F.R.); snezanaskobalj@gmail.com (S.S.); susanne.zielke@mail.de (S.Z.); xenia_bogdanovic@web.de (X.B.); paula.grieger@uksh.de (P.G.); j-rennecke@t-online.de (J.R.); arndt.rolfs@web.de (A.R.)">
<meta name="citation_author" content="Volha Skrahina">
<meta name="citation_author_institution" content="CENTOGENE GmbH, 18055 Rostock, Germany; sabine.roesner@centogene.com (S.R.); luba.pardo@centogene.com (L.M.P.); aida.bertoli-avella@centogene.com (A.M.B.-A.); skrahinavolha@gmail.com (V.S.); engel.pierre@gmail.com (P.E.); sabine.schroeder@centogene.com (S.S.); susan.zielske@centogene.com (S.Z.); valerie.bonke@centogene.com (V.B.); gina.westphal@centogene.com (G.W.); felix-reder@gmx.de (F.R.); snezanaskobalj@gmail.com (S.S.); susanne.zielke@mail.de (S.Z.); xenia_bogdanovic@web.de (X.B.); paula.grieger@uksh.de (P.G.); j-rennecke@t-online.de (J.R.); arndt.rolfs@web.de (A.R.)">
<meta name="citation_author" content="Pierre Engel">
<meta name="citation_author_institution" content="CENTOGENE GmbH, 18055 Rostock, Germany; sabine.roesner@centogene.com (S.R.); luba.pardo@centogene.com (L.M.P.); aida.bertoli-avella@centogene.com (A.M.B.-A.); skrahinavolha@gmail.com (V.S.); engel.pierre@gmail.com (P.E.); sabine.schroeder@centogene.com (S.S.); susan.zielske@centogene.com (S.Z.); valerie.bonke@centogene.com (V.B.); gina.westphal@centogene.com (G.W.); felix-reder@gmx.de (F.R.); snezanaskobalj@gmail.com (S.S.); susanne.zielke@mail.de (S.Z.); xenia_bogdanovic@web.de (X.B.); paula.grieger@uksh.de (P.G.); j-rennecke@t-online.de (J.R.); arndt.rolfs@web.de (A.R.)">
<meta name="citation_author" content="Sabine Schröder">
<meta name="citation_author_institution" content="CENTOGENE GmbH, 18055 Rostock, Germany; sabine.roesner@centogene.com (S.R.); luba.pardo@centogene.com (L.M.P.); aida.bertoli-avella@centogene.com (A.M.B.-A.); skrahinavolha@gmail.com (V.S.); engel.pierre@gmail.com (P.E.); sabine.schroeder@centogene.com (S.S.); susan.zielske@centogene.com (S.Z.); valerie.bonke@centogene.com (V.B.); gina.westphal@centogene.com (G.W.); felix-reder@gmx.de (F.R.); snezanaskobalj@gmail.com (S.S.); susanne.zielke@mail.de (S.Z.); xenia_bogdanovic@web.de (X.B.); paula.grieger@uksh.de (P.G.); j-rennecke@t-online.de (J.R.); arndt.rolfs@web.de (A.R.)">
<meta name="citation_author" content="Susan Zielske">
<meta name="citation_author_institution" content="CENTOGENE GmbH, 18055 Rostock, Germany; sabine.roesner@centogene.com (S.R.); luba.pardo@centogene.com (L.M.P.); aida.bertoli-avella@centogene.com (A.M.B.-A.); skrahinavolha@gmail.com (V.S.); engel.pierre@gmail.com (P.E.); sabine.schroeder@centogene.com (S.S.); susan.zielske@centogene.com (S.Z.); valerie.bonke@centogene.com (V.B.); gina.westphal@centogene.com (G.W.); felix-reder@gmx.de (F.R.); snezanaskobalj@gmail.com (S.S.); susanne.zielke@mail.de (S.Z.); xenia_bogdanovic@web.de (X.B.); paula.grieger@uksh.de (P.G.); j-rennecke@t-online.de (J.R.); arndt.rolfs@web.de (A.R.)">
<meta name="citation_author" content="Valerie Bonke">
<meta name="citation_author_institution" content="CENTOGENE GmbH, 18055 Rostock, Germany; sabine.roesner@centogene.com (S.R.); luba.pardo@centogene.com (L.M.P.); aida.bertoli-avella@centogene.com (A.M.B.-A.); skrahinavolha@gmail.com (V.S.); engel.pierre@gmail.com (P.E.); sabine.schroeder@centogene.com (S.S.); susan.zielske@centogene.com (S.Z.); valerie.bonke@centogene.com (V.B.); gina.westphal@centogene.com (G.W.); felix-reder@gmx.de (F.R.); snezanaskobalj@gmail.com (S.S.); susanne.zielke@mail.de (S.Z.); xenia_bogdanovic@web.de (X.B.); paula.grieger@uksh.de (P.G.); j-rennecke@t-online.de (J.R.); arndt.rolfs@web.de (A.R.)">
<meta name="citation_author" content="Janett Kreth">
<meta name="citation_author_institution" content="CENTOGENE GmbH, 18055 Rostock, Germany; sabine.roesner@centogene.com (S.R.); luba.pardo@centogene.com (L.M.P.); aida.bertoli-avella@centogene.com (A.M.B.-A.); skrahinavolha@gmail.com (V.S.); engel.pierre@gmail.com (P.E.); sabine.schroeder@centogene.com (S.S.); susan.zielske@centogene.com (S.Z.); valerie.bonke@centogene.com (V.B.); gina.westphal@centogene.com (G.W.); felix-reder@gmx.de (F.R.); snezanaskobalj@gmail.com (S.S.); susanne.zielke@mail.de (S.Z.); xenia_bogdanovic@web.de (X.B.); paula.grieger@uksh.de (P.G.); j-rennecke@t-online.de (J.R.); arndt.rolfs@web.de (A.R.)">
<meta name="citation_author" content="Gina Westphal">
<meta name="citation_author_institution" content="CENTOGENE GmbH, 18055 Rostock, Germany; sabine.roesner@centogene.com (S.R.); luba.pardo@centogene.com (L.M.P.); aida.bertoli-avella@centogene.com (A.M.B.-A.); skrahinavolha@gmail.com (V.S.); engel.pierre@gmail.com (P.E.); sabine.schroeder@centogene.com (S.S.); susan.zielske@centogene.com (S.Z.); valerie.bonke@centogene.com (V.B.); gina.westphal@centogene.com (G.W.); felix-reder@gmx.de (F.R.); snezanaskobalj@gmail.com (S.S.); susanne.zielke@mail.de (S.Z.); xenia_bogdanovic@web.de (X.B.); paula.grieger@uksh.de (P.G.); j-rennecke@t-online.de (J.R.); arndt.rolfs@web.de (A.R.)">
<meta name="citation_author" content="Felix Reder">
<meta name="citation_author_institution" content="CENTOGENE GmbH, 18055 Rostock, Germany; sabine.roesner@centogene.com (S.R.); luba.pardo@centogene.com (L.M.P.); aida.bertoli-avella@centogene.com (A.M.B.-A.); skrahinavolha@gmail.com (V.S.); engel.pierre@gmail.com (P.E.); sabine.schroeder@centogene.com (S.S.); susan.zielske@centogene.com (S.Z.); valerie.bonke@centogene.com (V.B.); gina.westphal@centogene.com (G.W.); felix-reder@gmx.de (F.R.); snezanaskobalj@gmail.com (S.S.); susanne.zielke@mail.de (S.Z.); xenia_bogdanovic@web.de (X.B.); paula.grieger@uksh.de (P.G.); j-rennecke@t-online.de (J.R.); arndt.rolfs@web.de (A.R.)">
<meta name="citation_author" content="Snezana Skobalj">
<meta name="citation_author_institution" content="CENTOGENE GmbH, 18055 Rostock, Germany; sabine.roesner@centogene.com (S.R.); luba.pardo@centogene.com (L.M.P.); aida.bertoli-avella@centogene.com (A.M.B.-A.); skrahinavolha@gmail.com (V.S.); engel.pierre@gmail.com (P.E.); sabine.schroeder@centogene.com (S.S.); susan.zielske@centogene.com (S.Z.); valerie.bonke@centogene.com (V.B.); gina.westphal@centogene.com (G.W.); felix-reder@gmx.de (F.R.); snezanaskobalj@gmail.com (S.S.); susanne.zielke@mail.de (S.Z.); xenia_bogdanovic@web.de (X.B.); paula.grieger@uksh.de (P.G.); j-rennecke@t-online.de (J.R.); arndt.rolfs@web.de (A.R.)">
<meta name="citation_author" content="Susanne Zielke">
<meta name="citation_author_institution" content="CENTOGENE GmbH, 18055 Rostock, Germany; sabine.roesner@centogene.com (S.R.); luba.pardo@centogene.com (L.M.P.); aida.bertoli-avella@centogene.com (A.M.B.-A.); skrahinavolha@gmail.com (V.S.); engel.pierre@gmail.com (P.E.); sabine.schroeder@centogene.com (S.S.); susan.zielske@centogene.com (S.Z.); valerie.bonke@centogene.com (V.B.); gina.westphal@centogene.com (G.W.); felix-reder@gmx.de (F.R.); snezanaskobalj@gmail.com (S.S.); susanne.zielke@mail.de (S.Z.); xenia_bogdanovic@web.de (X.B.); paula.grieger@uksh.de (P.G.); j-rennecke@t-online.de (J.R.); arndt.rolfs@web.de (A.R.)">
<meta name="citation_author" content="Xenia Bogdanovic">
<meta name="citation_author_institution" content="CENTOGENE GmbH, 18055 Rostock, Germany; sabine.roesner@centogene.com (S.R.); luba.pardo@centogene.com (L.M.P.); aida.bertoli-avella@centogene.com (A.M.B.-A.); skrahinavolha@gmail.com (V.S.); engel.pierre@gmail.com (P.E.); sabine.schroeder@centogene.com (S.S.); susan.zielske@centogene.com (S.Z.); valerie.bonke@centogene.com (V.B.); gina.westphal@centogene.com (G.W.); felix-reder@gmx.de (F.R.); snezanaskobalj@gmail.com (S.S.); susanne.zielke@mail.de (S.Z.); xenia_bogdanovic@web.de (X.B.); paula.grieger@uksh.de (P.G.); j-rennecke@t-online.de (J.R.); arndt.rolfs@web.de (A.R.)">
<meta name="citation_author" content="Paula Grieger">
<meta name="citation_author_institution" content="CENTOGENE GmbH, 18055 Rostock, Germany; sabine.roesner@centogene.com (S.R.); luba.pardo@centogene.com (L.M.P.); aida.bertoli-avella@centogene.com (A.M.B.-A.); skrahinavolha@gmail.com (V.S.); engel.pierre@gmail.com (P.E.); sabine.schroeder@centogene.com (S.S.); susan.zielske@centogene.com (S.Z.); valerie.bonke@centogene.com (V.B.); gina.westphal@centogene.com (G.W.); felix-reder@gmx.de (F.R.); snezanaskobalj@gmail.com (S.S.); susanne.zielke@mail.de (S.Z.); xenia_bogdanovic@web.de (X.B.); paula.grieger@uksh.de (P.G.); j-rennecke@t-online.de (J.R.); arndt.rolfs@web.de (A.R.)">
<meta name="citation_author" content="Jörg Rennecke">
<meta name="citation_author_institution" content="CENTOGENE GmbH, 18055 Rostock, Germany; sabine.roesner@centogene.com (S.R.); luba.pardo@centogene.com (L.M.P.); aida.bertoli-avella@centogene.com (A.M.B.-A.); skrahinavolha@gmail.com (V.S.); engel.pierre@gmail.com (P.E.); sabine.schroeder@centogene.com (S.S.); susan.zielske@centogene.com (S.Z.); valerie.bonke@centogene.com (V.B.); gina.westphal@centogene.com (G.W.); felix-reder@gmx.de (F.R.); snezanaskobalj@gmail.com (S.S.); susanne.zielke@mail.de (S.Z.); xenia_bogdanovic@web.de (X.B.); paula.grieger@uksh.de (P.G.); j-rennecke@t-online.de (J.R.); arndt.rolfs@web.de (A.R.)">
<meta name="citation_author" content="Thomas Skripuletz">
<meta name="citation_author_institution" content="Department of Neurology, Hannover Medical School, 30625 Hannover, Germany; skripuletz.thomas@mh-hannover.de">
<meta name="citation_author_institution" content="Amyloidosis Center of Lower Saxony, Hannover Medical School, 30625 Hannover, Germany">
<meta name="citation_author" content="Monica Patten">
<meta name="citation_author_institution" content="Department of Cardiology, University Heart and Vascular Center, 20148 Hamburg, Germany; patten@uke.de">
<meta name="citation_author" content="Birgit Aßmus">
<meta name="citation_author_institution" content="Department of Cardiology and Angiology, University Hospital Giessen and Marburg, 35043 Marburg, Germany; birgit.assmus@innere.med.uni-giessen.de">
<meta name="citation_author" content="Katrin Hahn">
<meta name="citation_author_institution" content="Department of Neurology, Charitè–Universitätsmedizin, Amyloidosis Center Charité, 10117 Berlin, Germany; katrin.hahn@charite.de">
<meta name="citation_author_institution" content="Amyloidosis Center Charité Berlin (ACCB), Charité Universitätsmedizin, 10117 Berlin, Germany">
<meta name="citation_author" content="Arndt Rolfs">
<meta name="citation_author_institution" content="CENTOGENE GmbH, 18055 Rostock, Germany; sabine.roesner@centogene.com (S.R.); luba.pardo@centogene.com (L.M.P.); aida.bertoli-avella@centogene.com (A.M.B.-A.); skrahinavolha@gmail.com (V.S.); engel.pierre@gmail.com (P.E.); sabine.schroeder@centogene.com (S.S.); susan.zielske@centogene.com (S.Z.); valerie.bonke@centogene.com (V.B.); gina.westphal@centogene.com (G.W.); felix-reder@gmx.de (F.R.); snezanaskobalj@gmail.com (S.S.); susanne.zielke@mail.de (S.Z.); xenia_bogdanovic@web.de (X.B.); paula.grieger@uksh.de (P.G.); j-rennecke@t-online.de (J.R.); arndt.rolfs@web.de (A.R.)">
<meta name="citation_author_institution" content="RCV GmbH, Institute for Rare Disease Diagnostics, 10629 Berlin, Germany">
<meta name="citation_author" content="Peter Bauer">
<meta name="citation_author_institution" content="CENTOGENE GmbH, 18055 Rostock, Germany; sabine.roesner@centogene.com (S.R.); luba.pardo@centogene.com (L.M.P.); aida.bertoli-avella@centogene.com (A.M.B.-A.); skrahinavolha@gmail.com (V.S.); engel.pierre@gmail.com (P.E.); sabine.schroeder@centogene.com (S.S.); susan.zielske@centogene.com (S.Z.); valerie.bonke@centogene.com (V.B.); gina.westphal@centogene.com (G.W.); felix-reder@gmx.de (F.R.); snezanaskobalj@gmail.com (S.S.); susanne.zielke@mail.de (S.Z.); xenia_bogdanovic@web.de (X.B.); paula.grieger@uksh.de (P.G.); j-rennecke@t-online.de (J.R.); arndt.rolfs@web.de (A.R.)">
<meta name="citation_author_institution" content="Medical Faculty, University Rostock, 18057 Rostock, Germany">
<meta name="citation_publication_date" content="2024 Oct 17">
<meta name="citation_volume" content="13">
<meta name="citation_issue" content="20">
<meta name="citation_firstpage" content="6197">
<meta name="citation_doi" content="10.3390/jcm13206197">
<meta name="citation_pmid" content="39458146">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC11508262/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC11508262/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC11508262/pdf/jcm-13-06197.pdf">
<meta name="description" content="Background: Hereditary transthyretin-related amyloidosis is a clinically heterogeneous autosomal dominant disease caused by pathogenic variants in the TTR gene (hATTR amyloidosis). Objective: The current study describes the demographic, clinical, ...">
<meta name="og:title" content="Hereditary Transthyretin-Related Amyloidosis Ongoing Observational Study: A Baseline Report of the First 3167 Participants">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Background: Hereditary transthyretin-related amyloidosis is a clinically heterogeneous autosomal dominant disease caused by pathogenic variants in the TTR gene (hATTR amyloidosis). Objective: The current study describes the demographic, clinical, ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC11508262/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://pmc.ncbi.nlm.nih.gov/search/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="11508262">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.3390/jcm13206197"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/jcm-13-06197.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC11508262%2F%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/11508262/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/11508262/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC11508262/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-jclinmed.png" alt="Journal of Clinical Medicine logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Journal of Clinical Medicine" title="Link to Journal of Clinical Medicine" shape="default" href="http://www.mdpi.com/journal/jcm" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">J Clin Med</button></div>. 2024 Oct 17;13(20):6197. doi: <a href="https://doi.org/10.3390/jcm13206197" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.3390/jcm13206197</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://pmc.ncbi.nlm.nih.gov/search/?term=%22J%20Clin%20Med%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22J%20Clin%20Med%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22J%20Clin%20Med%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22J%20Clin%20Med%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Hereditary Transthyretin-Related Amyloidosis Ongoing Observational Study: A Baseline Report of the First 3167 Participants</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22R%C3%B6sner%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Sabine Rösner</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Sabine Rösner</span></h3>
<div class="p">
<sup>1</sup>CENTOGENE GmbH, 18055 Rostock, Germany; sabine.roesner@centogene.com (S.R.); luba.pardo@centogene.com (L.M.P.); aida.bertoli-avella@centogene.com (A.M.B.-A.); skrahinavolha@gmail.com (V.S.); engel.pierre@gmail.com (P.E.); sabine.schroeder@centogene.com (S.S.); susan.zielske@centogene.com (S.Z.); valerie.bonke@centogene.com (V.B.); gina.westphal@centogene.com (G.W.); felix-reder@gmx.de (F.R.); snezanaskobalj@gmail.com (S.S.); susanne.zielke@mail.de (S.Z.); xenia_bogdanovic@web.de (X.B.); paula.grieger@uksh.de (P.G.); j-rennecke@t-online.de (J.R.); arndt.rolfs@web.de (A.R.)</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22R%C3%B6sner%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Sabine Rösner</span></a>
</div>
</div>
<sup>1,</sup><sup>†</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Pardo%20LM%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Luba M Pardo</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Luba M Pardo</span></h3>
<div class="p">
<sup>1</sup>CENTOGENE GmbH, 18055 Rostock, Germany; sabine.roesner@centogene.com (S.R.); luba.pardo@centogene.com (L.M.P.); aida.bertoli-avella@centogene.com (A.M.B.-A.); skrahinavolha@gmail.com (V.S.); engel.pierre@gmail.com (P.E.); sabine.schroeder@centogene.com (S.S.); susan.zielske@centogene.com (S.Z.); valerie.bonke@centogene.com (V.B.); gina.westphal@centogene.com (G.W.); felix-reder@gmx.de (F.R.); snezanaskobalj@gmail.com (S.S.); susanne.zielke@mail.de (S.Z.); xenia_bogdanovic@web.de (X.B.); paula.grieger@uksh.de (P.G.); j-rennecke@t-online.de (J.R.); arndt.rolfs@web.de (A.R.)</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Pardo%20LM%22%5BAuthor%5D" class="usa-link"><span class="name western">Luba M Pardo</span></a>
</div>
</div>
<sup>1,</sup><sup>†</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Bertoli-Avella%20AM%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Aida M Bertoli-Avella</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Aida M Bertoli-Avella</span></h3>
<div class="p">
<sup>1</sup>CENTOGENE GmbH, 18055 Rostock, Germany; sabine.roesner@centogene.com (S.R.); luba.pardo@centogene.com (L.M.P.); aida.bertoli-avella@centogene.com (A.M.B.-A.); skrahinavolha@gmail.com (V.S.); engel.pierre@gmail.com (P.E.); sabine.schroeder@centogene.com (S.S.); susan.zielske@centogene.com (S.Z.); valerie.bonke@centogene.com (V.B.); gina.westphal@centogene.com (G.W.); felix-reder@gmx.de (F.R.); snezanaskobalj@gmail.com (S.S.); susanne.zielke@mail.de (S.Z.); xenia_bogdanovic@web.de (X.B.); paula.grieger@uksh.de (P.G.); j-rennecke@t-online.de (J.R.); arndt.rolfs@web.de (A.R.)</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Bertoli-Avella%20AM%22%5BAuthor%5D" class="usa-link"><span class="name western">Aida M Bertoli-Avella</span></a>
</div>
</div>
<sup>1,</sup><sup>‡</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Skrahina%20V%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Volha Skrahina</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Volha Skrahina</span></h3>
<div class="p">
<sup>1</sup>CENTOGENE GmbH, 18055 Rostock, Germany; sabine.roesner@centogene.com (S.R.); luba.pardo@centogene.com (L.M.P.); aida.bertoli-avella@centogene.com (A.M.B.-A.); skrahinavolha@gmail.com (V.S.); engel.pierre@gmail.com (P.E.); sabine.schroeder@centogene.com (S.S.); susan.zielske@centogene.com (S.Z.); valerie.bonke@centogene.com (V.B.); gina.westphal@centogene.com (G.W.); felix-reder@gmx.de (F.R.); snezanaskobalj@gmail.com (S.S.); susanne.zielke@mail.de (S.Z.); xenia_bogdanovic@web.de (X.B.); paula.grieger@uksh.de (P.G.); j-rennecke@t-online.de (J.R.); arndt.rolfs@web.de (A.R.)</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Skrahina%20V%22%5BAuthor%5D" class="usa-link"><span class="name western">Volha Skrahina</span></a>
</div>
</div>
<sup>1,</sup><sup>‡</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Engel%20P%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Pierre Engel</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Pierre Engel</span></h3>
<div class="p">
<sup>1</sup>CENTOGENE GmbH, 18055 Rostock, Germany; sabine.roesner@centogene.com (S.R.); luba.pardo@centogene.com (L.M.P.); aida.bertoli-avella@centogene.com (A.M.B.-A.); skrahinavolha@gmail.com (V.S.); engel.pierre@gmail.com (P.E.); sabine.schroeder@centogene.com (S.S.); susan.zielske@centogene.com (S.Z.); valerie.bonke@centogene.com (V.B.); gina.westphal@centogene.com (G.W.); felix-reder@gmx.de (F.R.); snezanaskobalj@gmail.com (S.S.); susanne.zielke@mail.de (S.Z.); xenia_bogdanovic@web.de (X.B.); paula.grieger@uksh.de (P.G.); j-rennecke@t-online.de (J.R.); arndt.rolfs@web.de (A.R.)</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Engel%20P%22%5BAuthor%5D" class="usa-link"><span class="name western">Pierre Engel</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Schr%C3%B6der%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Sabine Schröder</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Sabine Schröder</span></h3>
<div class="p">
<sup>1</sup>CENTOGENE GmbH, 18055 Rostock, Germany; sabine.roesner@centogene.com (S.R.); luba.pardo@centogene.com (L.M.P.); aida.bertoli-avella@centogene.com (A.M.B.-A.); skrahinavolha@gmail.com (V.S.); engel.pierre@gmail.com (P.E.); sabine.schroeder@centogene.com (S.S.); susan.zielske@centogene.com (S.Z.); valerie.bonke@centogene.com (V.B.); gina.westphal@centogene.com (G.W.); felix-reder@gmx.de (F.R.); snezanaskobalj@gmail.com (S.S.); susanne.zielke@mail.de (S.Z.); xenia_bogdanovic@web.de (X.B.); paula.grieger@uksh.de (P.G.); j-rennecke@t-online.de (J.R.); arndt.rolfs@web.de (A.R.)</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Schr%C3%B6der%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Sabine Schröder</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zielske%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Susan Zielske</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Susan Zielske</span></h3>
<div class="p">
<sup>1</sup>CENTOGENE GmbH, 18055 Rostock, Germany; sabine.roesner@centogene.com (S.R.); luba.pardo@centogene.com (L.M.P.); aida.bertoli-avella@centogene.com (A.M.B.-A.); skrahinavolha@gmail.com (V.S.); engel.pierre@gmail.com (P.E.); sabine.schroeder@centogene.com (S.S.); susan.zielske@centogene.com (S.Z.); valerie.bonke@centogene.com (V.B.); gina.westphal@centogene.com (G.W.); felix-reder@gmx.de (F.R.); snezanaskobalj@gmail.com (S.S.); susanne.zielke@mail.de (S.Z.); xenia_bogdanovic@web.de (X.B.); paula.grieger@uksh.de (P.G.); j-rennecke@t-online.de (J.R.); arndt.rolfs@web.de (A.R.)</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zielske%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Susan Zielske</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Bonke%20V%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Valerie Bonke</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Valerie Bonke</span></h3>
<div class="p">
<sup>1</sup>CENTOGENE GmbH, 18055 Rostock, Germany; sabine.roesner@centogene.com (S.R.); luba.pardo@centogene.com (L.M.P.); aida.bertoli-avella@centogene.com (A.M.B.-A.); skrahinavolha@gmail.com (V.S.); engel.pierre@gmail.com (P.E.); sabine.schroeder@centogene.com (S.S.); susan.zielske@centogene.com (S.Z.); valerie.bonke@centogene.com (V.B.); gina.westphal@centogene.com (G.W.); felix-reder@gmx.de (F.R.); snezanaskobalj@gmail.com (S.S.); susanne.zielke@mail.de (S.Z.); xenia_bogdanovic@web.de (X.B.); paula.grieger@uksh.de (P.G.); j-rennecke@t-online.de (J.R.); arndt.rolfs@web.de (A.R.)</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Bonke%20V%22%5BAuthor%5D" class="usa-link"><span class="name western">Valerie Bonke</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kreth%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id9"><span class="name western">Janett Kreth</span></a><div hidden="hidden" id="id9">
<h3><span class="name western">Janett Kreth</span></h3>
<div class="p">
<sup>1</sup>CENTOGENE GmbH, 18055 Rostock, Germany; sabine.roesner@centogene.com (S.R.); luba.pardo@centogene.com (L.M.P.); aida.bertoli-avella@centogene.com (A.M.B.-A.); skrahinavolha@gmail.com (V.S.); engel.pierre@gmail.com (P.E.); sabine.schroeder@centogene.com (S.S.); susan.zielske@centogene.com (S.Z.); valerie.bonke@centogene.com (V.B.); gina.westphal@centogene.com (G.W.); felix-reder@gmx.de (F.R.); snezanaskobalj@gmail.com (S.S.); susanne.zielke@mail.de (S.Z.); xenia_bogdanovic@web.de (X.B.); paula.grieger@uksh.de (P.G.); j-rennecke@t-online.de (J.R.); arndt.rolfs@web.de (A.R.)</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kreth%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Janett Kreth</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Westphal%20G%22%5BAuthor%5D" class="usa-link" aria-describedby="id10"><span class="name western">Gina Westphal</span></a><div hidden="hidden" id="id10">
<h3><span class="name western">Gina Westphal</span></h3>
<div class="p">
<sup>1</sup>CENTOGENE GmbH, 18055 Rostock, Germany; sabine.roesner@centogene.com (S.R.); luba.pardo@centogene.com (L.M.P.); aida.bertoli-avella@centogene.com (A.M.B.-A.); skrahinavolha@gmail.com (V.S.); engel.pierre@gmail.com (P.E.); sabine.schroeder@centogene.com (S.S.); susan.zielske@centogene.com (S.Z.); valerie.bonke@centogene.com (V.B.); gina.westphal@centogene.com (G.W.); felix-reder@gmx.de (F.R.); snezanaskobalj@gmail.com (S.S.); susanne.zielke@mail.de (S.Z.); xenia_bogdanovic@web.de (X.B.); paula.grieger@uksh.de (P.G.); j-rennecke@t-online.de (J.R.); arndt.rolfs@web.de (A.R.)</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Westphal%20G%22%5BAuthor%5D" class="usa-link"><span class="name western">Gina Westphal</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Reder%20F%22%5BAuthor%5D" class="usa-link" aria-describedby="id11"><span class="name western">Felix Reder</span></a><div hidden="hidden" id="id11">
<h3><span class="name western">Felix Reder</span></h3>
<div class="p">
<sup>1</sup>CENTOGENE GmbH, 18055 Rostock, Germany; sabine.roesner@centogene.com (S.R.); luba.pardo@centogene.com (L.M.P.); aida.bertoli-avella@centogene.com (A.M.B.-A.); skrahinavolha@gmail.com (V.S.); engel.pierre@gmail.com (P.E.); sabine.schroeder@centogene.com (S.S.); susan.zielske@centogene.com (S.Z.); valerie.bonke@centogene.com (V.B.); gina.westphal@centogene.com (G.W.); felix-reder@gmx.de (F.R.); snezanaskobalj@gmail.com (S.S.); susanne.zielke@mail.de (S.Z.); xenia_bogdanovic@web.de (X.B.); paula.grieger@uksh.de (P.G.); j-rennecke@t-online.de (J.R.); arndt.rolfs@web.de (A.R.)</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Reder%20F%22%5BAuthor%5D" class="usa-link"><span class="name western">Felix Reder</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Skobalj%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id12"><span class="name western">Snezana Skobalj</span></a><div hidden="hidden" id="id12">
<h3><span class="name western">Snezana Skobalj</span></h3>
<div class="p">
<sup>1</sup>CENTOGENE GmbH, 18055 Rostock, Germany; sabine.roesner@centogene.com (S.R.); luba.pardo@centogene.com (L.M.P.); aida.bertoli-avella@centogene.com (A.M.B.-A.); skrahinavolha@gmail.com (V.S.); engel.pierre@gmail.com (P.E.); sabine.schroeder@centogene.com (S.S.); susan.zielske@centogene.com (S.Z.); valerie.bonke@centogene.com (V.B.); gina.westphal@centogene.com (G.W.); felix-reder@gmx.de (F.R.); snezanaskobalj@gmail.com (S.S.); susanne.zielke@mail.de (S.Z.); xenia_bogdanovic@web.de (X.B.); paula.grieger@uksh.de (P.G.); j-rennecke@t-online.de (J.R.); arndt.rolfs@web.de (A.R.)</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Skobalj%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Snezana Skobalj</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zielke%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id13"><span class="name western">Susanne Zielke</span></a><div hidden="hidden" id="id13">
<h3><span class="name western">Susanne Zielke</span></h3>
<div class="p">
<sup>1</sup>CENTOGENE GmbH, 18055 Rostock, Germany; sabine.roesner@centogene.com (S.R.); luba.pardo@centogene.com (L.M.P.); aida.bertoli-avella@centogene.com (A.M.B.-A.); skrahinavolha@gmail.com (V.S.); engel.pierre@gmail.com (P.E.); sabine.schroeder@centogene.com (S.S.); susan.zielske@centogene.com (S.Z.); valerie.bonke@centogene.com (V.B.); gina.westphal@centogene.com (G.W.); felix-reder@gmx.de (F.R.); snezanaskobalj@gmail.com (S.S.); susanne.zielke@mail.de (S.Z.); xenia_bogdanovic@web.de (X.B.); paula.grieger@uksh.de (P.G.); j-rennecke@t-online.de (J.R.); arndt.rolfs@web.de (A.R.)</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zielke%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Susanne Zielke</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Bogdanovic%20X%22%5BAuthor%5D" class="usa-link" aria-describedby="id14"><span class="name western">Xenia Bogdanovic</span></a><div hidden="hidden" id="id14">
<h3><span class="name western">Xenia Bogdanovic</span></h3>
<div class="p">
<sup>1</sup>CENTOGENE GmbH, 18055 Rostock, Germany; sabine.roesner@centogene.com (S.R.); luba.pardo@centogene.com (L.M.P.); aida.bertoli-avella@centogene.com (A.M.B.-A.); skrahinavolha@gmail.com (V.S.); engel.pierre@gmail.com (P.E.); sabine.schroeder@centogene.com (S.S.); susan.zielske@centogene.com (S.Z.); valerie.bonke@centogene.com (V.B.); gina.westphal@centogene.com (G.W.); felix-reder@gmx.de (F.R.); snezanaskobalj@gmail.com (S.S.); susanne.zielke@mail.de (S.Z.); xenia_bogdanovic@web.de (X.B.); paula.grieger@uksh.de (P.G.); j-rennecke@t-online.de (J.R.); arndt.rolfs@web.de (A.R.)</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Bogdanovic%20X%22%5BAuthor%5D" class="usa-link"><span class="name western">Xenia Bogdanovic</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Grieger%20P%22%5BAuthor%5D" class="usa-link" aria-describedby="id15"><span class="name western">Paula Grieger</span></a><div hidden="hidden" id="id15">
<h3><span class="name western">Paula Grieger</span></h3>
<div class="p">
<sup>1</sup>CENTOGENE GmbH, 18055 Rostock, Germany; sabine.roesner@centogene.com (S.R.); luba.pardo@centogene.com (L.M.P.); aida.bertoli-avella@centogene.com (A.M.B.-A.); skrahinavolha@gmail.com (V.S.); engel.pierre@gmail.com (P.E.); sabine.schroeder@centogene.com (S.S.); susan.zielske@centogene.com (S.Z.); valerie.bonke@centogene.com (V.B.); gina.westphal@centogene.com (G.W.); felix-reder@gmx.de (F.R.); snezanaskobalj@gmail.com (S.S.); susanne.zielke@mail.de (S.Z.); xenia_bogdanovic@web.de (X.B.); paula.grieger@uksh.de (P.G.); j-rennecke@t-online.de (J.R.); arndt.rolfs@web.de (A.R.)</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Grieger%20P%22%5BAuthor%5D" class="usa-link"><span class="name western">Paula Grieger</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Rennecke%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id16"><span class="name western">Jörg Rennecke</span></a><div hidden="hidden" id="id16">
<h3><span class="name western">Jörg Rennecke</span></h3>
<div class="p">
<sup>1</sup>CENTOGENE GmbH, 18055 Rostock, Germany; sabine.roesner@centogene.com (S.R.); luba.pardo@centogene.com (L.M.P.); aida.bertoli-avella@centogene.com (A.M.B.-A.); skrahinavolha@gmail.com (V.S.); engel.pierre@gmail.com (P.E.); sabine.schroeder@centogene.com (S.S.); susan.zielske@centogene.com (S.Z.); valerie.bonke@centogene.com (V.B.); gina.westphal@centogene.com (G.W.); felix-reder@gmx.de (F.R.); snezanaskobalj@gmail.com (S.S.); susanne.zielke@mail.de (S.Z.); xenia_bogdanovic@web.de (X.B.); paula.grieger@uksh.de (P.G.); j-rennecke@t-online.de (J.R.); arndt.rolfs@web.de (A.R.)</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Rennecke%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Jörg Rennecke</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Skripuletz%20T%22%5BAuthor%5D" class="usa-link" aria-describedby="id17"><span class="name western">Thomas Skripuletz</span></a><div hidden="hidden" id="id17">
<h3><span class="name western">Thomas Skripuletz</span></h3>
<div class="p">
<sup>2</sup>Department of Neurology, Hannover Medical School, 30625 Hannover, Germany; skripuletz.thomas@mh-hannover.de</div>
<div class="p">
<sup>3</sup>Amyloidosis Center of Lower Saxony, Hannover Medical School, 30625 Hannover, Germany</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Skripuletz%20T%22%5BAuthor%5D" class="usa-link"><span class="name western">Thomas Skripuletz</span></a>
</div>
</div>
<sup>2,</sup><sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Patten%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id18"><span class="name western">Monica Patten</span></a><div hidden="hidden" id="id18">
<h3><span class="name western">Monica Patten</span></h3>
<div class="p">
<sup>4</sup>Department of Cardiology, University Heart and Vascular Center, 20148 Hamburg, Germany; patten@uke.de</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Patten%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Monica Patten</span></a>
</div>
</div>
<sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22A%C3%9Fmus%20B%22%5BAuthor%5D" class="usa-link" aria-describedby="id19"><span class="name western">Birgit Aßmus</span></a><div hidden="hidden" id="id19">
<h3><span class="name western">Birgit Aßmus</span></h3>
<div class="p">
<sup>5</sup>Department of Cardiology and Angiology, University Hospital Giessen and Marburg, 35043 Marburg, Germany; birgit.assmus@innere.med.uni-giessen.de</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22A%C3%9Fmus%20B%22%5BAuthor%5D" class="usa-link"><span class="name western">Birgit Aßmus</span></a>
</div>
</div>
<sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hahn%20K%22%5BAuthor%5D" class="usa-link" aria-describedby="id20"><span class="name western">Katrin Hahn</span></a><div hidden="hidden" id="id20">
<h3><span class="name western">Katrin Hahn</span></h3>
<div class="p">
<sup>6</sup>Department of Neurology, Charitè–Universitätsmedizin, Amyloidosis Center Charité, 10117 Berlin, Germany; katrin.hahn@charite.de</div>
<div class="p">
<sup>7</sup>Amyloidosis Center Charité Berlin (ACCB), Charité Universitätsmedizin, 10117 Berlin, Germany</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hahn%20K%22%5BAuthor%5D" class="usa-link"><span class="name western">Katrin Hahn</span></a>
</div>
</div>
<sup>6,</sup><sup>7</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Rolfs%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id21"><span class="name western">Arndt Rolfs</span></a><div hidden="hidden" id="id21">
<h3><span class="name western">Arndt Rolfs</span></h3>
<div class="p">
<sup>1</sup>CENTOGENE GmbH, 18055 Rostock, Germany; sabine.roesner@centogene.com (S.R.); luba.pardo@centogene.com (L.M.P.); aida.bertoli-avella@centogene.com (A.M.B.-A.); skrahinavolha@gmail.com (V.S.); engel.pierre@gmail.com (P.E.); sabine.schroeder@centogene.com (S.S.); susan.zielske@centogene.com (S.Z.); valerie.bonke@centogene.com (V.B.); gina.westphal@centogene.com (G.W.); felix-reder@gmx.de (F.R.); snezanaskobalj@gmail.com (S.S.); susanne.zielke@mail.de (S.Z.); xenia_bogdanovic@web.de (X.B.); paula.grieger@uksh.de (P.G.); j-rennecke@t-online.de (J.R.); arndt.rolfs@web.de (A.R.)</div>
<div class="p">
<sup>8</sup>RCV GmbH, Institute for Rare Disease Diagnostics, 10629 Berlin, Germany</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Rolfs%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Arndt Rolfs</span></a>
</div>
</div>
<sup>1,</sup><sup>8,</sup><sup>§</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Bauer%20P%22%5BAuthor%5D" class="usa-link" aria-describedby="id22"><span class="name western">Peter Bauer</span></a><div hidden="hidden" id="id22">
<h3><span class="name western">Peter Bauer</span></h3>
<div class="p">
<sup>1</sup>CENTOGENE GmbH, 18055 Rostock, Germany; sabine.roesner@centogene.com (S.R.); luba.pardo@centogene.com (L.M.P.); aida.bertoli-avella@centogene.com (A.M.B.-A.); skrahinavolha@gmail.com (V.S.); engel.pierre@gmail.com (P.E.); sabine.schroeder@centogene.com (S.S.); susan.zielske@centogene.com (S.Z.); valerie.bonke@centogene.com (V.B.); gina.westphal@centogene.com (G.W.); felix-reder@gmx.de (F.R.); snezanaskobalj@gmail.com (S.S.); susanne.zielke@mail.de (S.Z.); xenia_bogdanovic@web.de (X.B.); paula.grieger@uksh.de (P.G.); j-rennecke@t-online.de (J.R.); arndt.rolfs@web.de (A.R.)</div>
<div class="p">
<sup>9</sup>Medical Faculty, University Rostock, 18057 Rostock, Germany</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Bauer%20P%22%5BAuthor%5D" class="usa-link"><span class="name western">Peter Bauer</span></a>, <span class="on-behalf-of">on behalf of the TRAM study</span>
</div>
</div>, <span class="on-behalf-of">on behalf of the TRAM study</span><sup>1,</sup><sup>9,</sup><sup>*,</sup><sup>§</sup>
</div>
<div class="cg p">Editor: <span class="name western">Manuel Martínez-Sellés</span>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="af1-jcm-13-06197">
<sup>1</sup>CENTOGENE GmbH, 18055 Rostock, Germany; sabine.roesner@centogene.com (S.R.); luba.pardo@centogene.com (L.M.P.); aida.bertoli-avella@centogene.com (A.M.B.-A.); skrahinavolha@gmail.com (V.S.); engel.pierre@gmail.com (P.E.); sabine.schroeder@centogene.com (S.S.); susan.zielske@centogene.com (S.Z.); valerie.bonke@centogene.com (V.B.); gina.westphal@centogene.com (G.W.); felix-reder@gmx.de (F.R.); snezanaskobalj@gmail.com (S.S.); susanne.zielke@mail.de (S.Z.); xenia_bogdanovic@web.de (X.B.); paula.grieger@uksh.de (P.G.); j-rennecke@t-online.de (J.R.); arndt.rolfs@web.de (A.R.)</div>
<div id="af2-jcm-13-06197">
<sup>2</sup>Department of Neurology, Hannover Medical School, 30625 Hannover, Germany; skripuletz.thomas@mh-hannover.de</div>
<div id="af3-jcm-13-06197">
<sup>3</sup>Amyloidosis Center of Lower Saxony, Hannover Medical School, 30625 Hannover, Germany</div>
<div id="af4-jcm-13-06197">
<sup>4</sup>Department of Cardiology, University Heart and Vascular Center, 20148 Hamburg, Germany; patten@uke.de</div>
<div id="af5-jcm-13-06197">
<sup>5</sup>Department of Cardiology and Angiology, University Hospital Giessen and Marburg, 35043 Marburg, Germany; birgit.assmus@innere.med.uni-giessen.de</div>
<div id="af6-jcm-13-06197">
<sup>6</sup>Department of Neurology, Charitè–Universitätsmedizin, Amyloidosis Center Charité, 10117 Berlin, Germany; katrin.hahn@charite.de</div>
<div id="af7-jcm-13-06197">
<sup>7</sup>Amyloidosis Center Charité Berlin (ACCB), Charité Universitätsmedizin, 10117 Berlin, Germany</div>
<div id="af8-jcm-13-06197">
<sup>8</sup>RCV GmbH, Institute for Rare Disease Diagnostics, 10629 Berlin, Germany</div>
<div id="af9-jcm-13-06197">
<sup>9</sup>Medical Faculty, University Rostock, 18057 Rostock, Germany</div>
<div class="author-notes p">
<div class="fn" id="c1-jcm-13-06197">
<sup>*</sup><p class="display-inline">Correspondence: <span>peter.bauer@centogene.com</span>; Tel.: +49-381-80113-511</p>
</div>
<div class="fn" id="fn1-jcm-13-06197">
<sup>†</sup><p class="display-inline">These authors contributed equally to this work.</p>
</div>
<div class="fn" id="fn2-jcm-13-06197">
<sup>‡</sup><p class="display-inline">These authors also contributed equally to this work.</p>
</div>
<div class="fn" id="fn3-jcm-13-06197">
<sup>§</sup><p class="display-inline">Shared last author on behalf of TRAM Study. Collaborators/Membership of the Group/Team Name is provided in the <a href="#app1-jcm-13-06197" class="usa-link">Supplementary Materials</a>.</p>
</div>
</div>
<h4 class="font-secondary">Roles</h4>
<div class="p">
<strong class="contrib"><span class="name western">Manuel Martínez-Sellés</span></strong>: <span class="role">Academic Editor</span>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2024 Sep 11; Revised 2024 Oct 12; Accepted 2024 Oct 13; Collection date 2024 Oct.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© 2024 by the authors.</div>
<p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<a href="https://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://creativecommons.org/licenses/by/4.0/</a>).</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC11508262  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/39458146/" class="usa-link">39458146</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>Abstract</h2>
<p><strong>Background</strong>: Hereditary transthyretin-related amyloidosis is a clinically heterogeneous autosomal dominant disease caused by pathogenic variants in the <em>TTR</em> gene (hATTR amyloidosis). <strong>Objective:</strong> The current study describes the demographic, clinical, and genetic characteristics of patients with suspected hATTR amyloidosis. <strong>Methods</strong>: This study is part of the “Hereditary transthyretin-related amyloidosis and longitudinal monitoring of <em>TTR</em>-positive patients” (TRAMmoni<em>TTR</em>) study. This study included 3167 participants, along with their clinical details. Principal component (PC) analysis was used to analyze their clinical symptomatology. Next-generation sequencing of the <em>TTR</em> gene was performed and genotype–phenotype relationships were investigated. We compared the demographic and clinical characteristics using the principal components (PCs) and also compared participants with and without the <em>TTR</em> pathogenic variants. <strong>Results:</strong> We identified five main clinical phenotypes out of 22 single symptoms that explained 49% of the variation. The first two PCs referred to polyneuropathy and cardiomyopathy. We found significant differences between gender and PC-polyneuropathy and PC-cardiomyopathy, with male over-representation in the higher quantiles of PC-polyneuropathy and male under-representation in the lowest quantiles of PC-cardiomyopathy. We identified 92 participants with hATTR (3%), exhibiting 17 unique heterozygous <em>TTR</em> variants. The p.Val50Met variant was the most frequent. Furthermore, 503 participants (20%) were identified with ATTR and no relevant <em>TTR</em> variants (ATTRwt). We detected significant differences between the ATTRwt and hATTR groups, with male gender predominance in only the ATTRwt group and a positive family history of polyneuropathy and/or cardiomyopathy among the hATTR participants. <strong>Conclusions</strong>: The current clinical and genetic characterization of this cohort serves as a foundation for further longitudinal monitoring and assessment.</p>
<section id="kwd-group1" class="kwd-group"><p><strong>Keywords:</strong> hATTR amyloidosis, Hereditary Transthyretin-Related Amyloidosis, <em>TTR</em></p></section></section><section id="sec1-jcm-13-06197"><h2 class="pmc_sec_title">1. Introduction</h2>
<p>Transthyretin amyloidosis (ATTR amyloidosis) is a life-threatening disease caused by the deposition of misfolded transthyretin (TTR) protein amyloid fibrils in various tissues, leading to polyneuropathy and/or cardiomyopathy, among other clinical manifestations [<a href="#B1-jcm-13-06197" class="usa-link" aria-describedby="B1-jcm-13-06197">1</a>,<a href="#B2-jcm-13-06197" class="usa-link" aria-describedby="B2-jcm-13-06197">2</a>]. ATTR amyloidosis can be classified into two distinct forms: hereditary or variant ATTR amyloidosis (ATTRv amyloidosis) and wild-type ATTR amyloidosis (ATTRwt amyloidosis). ATTRv amyloidosis is an autosomal dominant disease caused by pathogenic variants in the <em>TTR</em> gene, which is located on chromosome 18 [<a href="#B3-jcm-13-06197" class="usa-link" aria-describedby="B3-jcm-13-06197">3</a>]. Pathogenic variants causing ATTRv amyloidosis were initially identified in 1984 by Saraiva et al., who reported the heterozygous p.Val50Met variant (legacy Val30Met, <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000371.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000371.4</a>:c.148G&gt;A; hereafter p.Val50Met) in a Portuguese family (4). To date, this is the most frequently reported variant in <em>TTR</em> [<a href="#B4-jcm-13-06197" class="usa-link" aria-describedby="B4-jcm-13-06197">4</a>]. There are over 200 <em>TTR</em> variants reported in the Human Genetics Mutation database HGMD; <a href="https://www.hgmd.cf.ac.uk/docs/articles.html" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.hgmd.cf.ac.uk/docs/articles.html</a> (accessed on 19 December 2023). In contrast, ATTRwt amyloidosis is ‘acquired’ and results from the accumulation of the ‘wild-type’ TTR protein. This form of the disease is more common in men and occurs in older age (&gt;60 years) [<a href="#B2-jcm-13-06197" class="usa-link" aria-describedby="B2-jcm-13-06197">2</a>].</p>
<p>The phenotypic spectrum of ATTRv amyloidosis is highly heterogeneous and encompasses polyneuropathy, carpal tunnel syndrome, autonomic insufficiency, cardiomyopathy, and gastrointestinal features, occasionally accompanied by vitreous opacities or renal insufficiency. As the disease progresses, gastrointestinal features with malabsorption, cachexia, incapacitating neuropathy, severe cardiac disturbances, and marked orthostatic hypotension become predominant [<a href="#B5-jcm-13-06197" class="usa-link" aria-describedby="B5-jcm-13-06197">5</a>]. Broadly, two primary phenotypes are recognized: polyneuropathy (PNP), which is characterized by autonomic dysregulation, cardiomyopathy (CM), or a blend of both neurological and cardiac features (1). Notably, adult-onset CM emerges as the prevailing presentation in ATTRwt amyloidosis, with a predilection in men [<a href="#B1-jcm-13-06197" class="usa-link" aria-describedby="B1-jcm-13-06197">1</a>].</p>
<p>The accurate diagnosis of ATTR amyloidosis poses remarkable challenges due to the disease’s clinical heterogeneity, low awareness of the disease, and clinical features that overlap with more prevalent conditions [<a href="#B1-jcm-13-06197" class="usa-link" aria-describedby="B1-jcm-13-06197">1</a>], particularly in geographical regions with a low prevalence of the causative variants. A better understanding of the disease holds the potential to facilitate earlier detection and enable timely intervention with approved disease-modifying therapies [<a href="#B6-jcm-13-06197" class="usa-link" aria-describedby="B6-jcm-13-06197">6</a>].</p>
<p>A comprehensive longitudinal observational study, the THAOS study, was conducted over a 14-year period [<a href="#B7-jcm-13-06197" class="usa-link" aria-describedby="B7-jcm-13-06197">7</a>] and provided valuable insights into the primary clinical features of ATTR amyloidosis, encompassing both the TTRv and TTRwt forms, across diverse geographical regions including North America, South America, Asia, Africa, and Europe. Notably, Portugal and the USA (United States of America) contribute the largest patient cohorts, amounting to 3135 individuals. However, the prevalence of pathogenic variants and the associated clinical manifestations in other regions remains poorly explored.</p>
<p>More recently, a multicentric observational initiative, the “Epidemiological Analysis for the Hereditary TransthyRetin-Related Amyloidosis” (TRAM) study, has been established. This study aimed to investigate the prevalence of hereditary ATTR (hATTR) amyloidosis among participants presenting with polyneuropathy (PNP) and/or cardiomyopathy (CM) who lacked an obvious etiology [<a href="#B8-jcm-13-06197" class="usa-link" aria-describedby="B8-jcm-13-06197">8</a>]. By broadening the scope of the investigation to encompass more regions and by focusing on participants with specific clinical presentations, the TRAM study seeks to enhance our understanding of hATTR prevalence and its associated clinical spectrum beyond previously studied populations.</p>
<p>A newly launched study, “Hereditary transthyretin-related amyloidosis and longitudinal monitoring of <em>TTR</em>-positive patients” (TRAMmoni<em>TTR</em>), is a continuation and expansion of the preceding TRAM epidemiological analysis [<a href="#B8-jcm-13-06197" class="usa-link" aria-describedby="B8-jcm-13-06197">8</a>]. It is expected to enroll a sizable cohort of 5000 participants from Germany. This ongoing study aims to delve deeper into the understanding of ATTRv amyloidosis and its progression (hereafter, we use hATTR to refer to ATTRv). In this paper, we describe the main demographic and clinical characteristics at baseline and <em>TTR</em> genetic results of the first 3167 participants. This characterization of the cohort serves as a foundation for longitudinal monitoring and analysis.</p></section><section id="sec2-jcm-13-06197"><h2 class="pmc_sec_title">2. Materials and Methods</h2>
<section id="sec2dot1-jcm-13-06197"><h3 class="pmc_sec_title">2.1. Study Design</h3>
<p>The genetic screening of an at-risk population for hereditary transthyretin-related amyloidosis and the longitudinal monitoring of <em>TTR</em>-positive subjects (the TRAMmoni<em>TTR</em> study) is a German epidemiological, multicentre, cohort study of participants at risk for hATTR, along with participants already diagnosed with hATTR. The list of centers and researchers involved in this study is provided in <a href="#app1-jcm-13-06197" class="usa-link">Table S1</a>. The follow-up of the clinical status covers 24 months (about 2 years). The TRAMmoni<em>TTR</em> study was designed as an extension of the earlier TRAM analysis epidemiological study [<a href="#B8-jcm-13-06197" class="usa-link" aria-describedby="B8-jcm-13-06197">8</a>] (concluded in September 2020) to obtain a deeper understanding of the disease. The main aim of the TRAMmoni<em>TTR</em> study is to monitor the clinical status of subjects who have tested positive for <em>TTR</em>, and the secondary aim is to explore hATTR prevalence in an at-risk population. The tertiary objective is to identify hATTR biomarkers. A detailed protocol is accessible from Clinical.Trials.gov; reference: <a href="https://clinicaltrials.gov/ct2/show/NCT03237494" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT03237494</a>; <a href="https://clinicaltrials.gov/search?cond=NCT03237494" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://clinicaltrials.gov/search?cond=NCT03237494</a> (accessed on 19 December 2023).</p>
<p>This ongoing study, started in October 2020 and with an expected conclusion in April 2025, aims to establish a cohort including 5000 participants. For this paper, we have included data derived from two distinct sources. Firstly, participants enrolled in the TRAMmoni<em>TTR</em> study between February 2021 and September 2023 form cohort 1 (<em>n</em> = 2518), with both clinical data and results from <em>TTR</em> genetic testing. Secondly, individuals included in the TRAM analysis, recruited from October 2020 to May 2021, constitute cohort 2 (<em>n</em> = 649), for whom both clinical and genetic data were also included. The inclusion criteria for the TRAM study were described in a previous publication [<a href="#B8-jcm-13-06197" class="usa-link" aria-describedby="B8-jcm-13-06197">8</a>]. These were as follows: (1) informed consent was obtained from the participant, (2) the participant was aged between 18 and 85 years, (3) the participant was diagnosed with CM and/or PNP of no obvious etiology, and (4) the participant has not undergone chemotherapy for any solid or hematological malignancies. The two cohorts were combined, given the similar clinical inclusion criteria. This current study is an in-depth examination of the clinical and genetic features seen across this cohort of 3167 participants.</p></section><section id="sec2dot2-jcm-13-06197"><h3 class="pmc_sec_title">2.2. Ethical Approval</h3>
<p>The research was carried out in accordance with the Declaration of Helsinki. The TRAMmoni<em>TTR</em> study was approved by the Ethical Committee of the Medical Faculty of the University of Rostock (approval A 2018-0069, date: 24 April 2018). Ethics approval was obtained for each participating center in Germany [<a href="#B6-jcm-13-06197" class="usa-link" aria-describedby="B6-jcm-13-06197">6</a>]. Informed consent was obtained from the referring physicians, patients, and/or their parents or legal guardians, including regarding the publication of anonymized individual details. The informed consent form is available in English and in several other languages at: <a href="https://www.centogene.com/downloads.html" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.centogene.com/downloads.html</a> (accessed on 19 December 2023).</p></section><section id="sec2dot3-jcm-13-06197"><h3 class="pmc_sec_title">2.3. Description of the Clinical Cases</h3>
<p>Inclusion criteria to participate in cohort 1 were: (i) age of 18 years and older; (ii) the participant had provided signed, informed consent; (iii) the participant had not undergone chemotherapy treatment for any carcinoma; (iv) the participant had not had any diagnosis of alcoholism according to international guidelines; and (v) the participant had at least two symptoms of the following: cardiomyopathy or polyneuropathy with no obvious etiology, atypical chronic inflammatory demyelinating polyneuropathy (CIDP) or motor neuron disease (MND), autonomic dysfunction, hypertrophic cardiomyopathy or heart failure with preserved ejection fraction left ventricular hypertrophy (LVH), bilateral carpal tunnel syndrome, spinal stenosis or spinal radiculopathy, gait disorders, ocular changes involving vitreous opacities, unexplained weight loss (&gt;5 kg), renal abnormalities, a family history of hATTR, the suspicion of ATTRwt amyloidosis based on imaging or biopsy, and not genetically tested for hATTR. In addition, either the participant has already received a diagnosis of hATTR, or the participant is a first- or second-degree relative of a patient diagnosed with hATTR in the study.</p>
<p>The eligible participants for this study indicating a risk of hATTR amyloidosis were genetically tested (see below). Those diagnosed with hATTR prior to enrolment underwent confirmatory genetic tests. Symptomatic or asymptomatic first- and second-degree family members of newly diagnosed participants who tested positive for hATTR were tested as well. The inclusion criteria for cohort 2 were the same as those from the previous epidemiological study (TRAM analysis) [<a href="#B8-jcm-13-06197" class="usa-link" aria-describedby="B8-jcm-13-06197">8</a>].</p></section><section id="sec2dot4-jcm-13-06197"><h3 class="pmc_sec_title">2.4. Genetic Testing</h3>
<p>All subjects gave blood samples (~1 mL blood), drawn into a dried blood spot (DBS) filter card known as a CentoCard<sup>®</sup> (CENTOGENE GmbH; Rostock, Germany). These cards were then sent to CENTOGENE laboratories (Rostock, Germany). Concurrently, the participants’ past medical history, medication, family history, and physical examination findings were recorded as an electronic case report form (eCRF). Upon arrival at CENTOGENE’s laboratory, a sequencing analysis of the <em>TTR</em> gene (<a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000371.3" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000371.3</a>) was performed. DNA was extracted from the CentoCard<sup>®</sup> using the Extracta DNA Prep Kit (QuantaBio, Beverly, MA, USA). The DNA was used in a multiplex PCR, generating 12 TTR-specific amplicons covering all coding exons and at least 20 bp exon-intron boundaries. Amplicons were pooled together and purified using AMPure XP beads (Beckman Coulter; Woerden, the Netherlands). A second PCR amplification procedure was performed, adding Illumina-compatible, patient-specific barcoded index primers to each amplicon pool. Following a second bead purification process, the samples were pooled for 150 bp paired-end sequencing on a MiSeq or NextSeq 500 instrument (Illumina Inc; München, Germany). The reads were aligned with bioinformatics methods and compared to the reference sequence <em>TTR</em> (<a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000371.3" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000371.3</a>) to identify the single-nucleotide variants (SNVs). All variants with a minor allele frequency (MAF) of less than 1% in the gnomAD database, and disease-causing variants reported in HGMD<sup>®</sup>; <a href="https://www.hgmd.cf.ac.uk/ac/index.php" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.hgmd.cf.ac.uk/ac/index.php</a> (accessed on 19 December 2023) in ClinVar, or in the CENTOGENE Biodatabank were evaluated. All variants were classified according to the general recommendations of the American College of Medical Genetics ACMG/AMP ClinGen Sequence Variant Interpretation.</p>
<p>The <em>TTR</em> test results were interpreted as positive (pathogenic or likely pathogenic—P/LP—variant), as unclear (variant of unknown significance—VUS), or as negative when no relevant variant was identified. Participants with an established/possible genetic diagnosis (positive <em>TTR</em> result or unclear result) were then further engaged in the study. First- and second-degree relatives of participants with a P/LP or VUS in the <em>TTR</em> gene were invited to the study site by a doctor connected to the study. The clinical history of subjects was thoroughly examined, and symptomatic and asymptomatic family members were offered enrollment in the TRAMmoni<em>TTR</em> study with subsequent genetic testing. Asymptomatic family members were given the option of genetic counseling before predictive genetic testing for hATTR. If testing was chosen, blood was collected and sent to CENTOGENE, with all participating family members receiving new study codes and their relation to the index subsequently documented.</p>
<p><em>TTR</em>-positive subjects, both symptomatic and asymptomatic, or with VUS in their <em>TTR</em> gene, were offered enrollment in a 24-month follow-up program. Over eight visits, each encompassing a physical examination, clinical information documentation, and blood sample collection, participants underwent biochemical analysis to establish their hATTR biomarkers.</p></section></section><section id="sec3-jcm-13-06197"><h2 class="pmc_sec_title">3. Statistical Analysis</h2>
<p>Descriptive statistics of the main demographic variables were presented as medians with inter-quantile range (IQR) and compared using the chi-squared test for categorical variables and the Mann–Whitney test for continuous variables. Cross tables were used to analyze the categorical data and differences across variables were tested using the chi-squared test, adjusting for post hoc pairwise analysis (correcting for multiple testing). All tests were considered significant if the <em>p</em>-values (or adjusted <em>p</em>-values) were lower than or equal to 0.05.</p>
<p>To understand the variations in the clinical symptoms of the participants of both cohorts, we used principal component analysis (PCA) as an exploratory analysis method (the results of the PCA are presented in the <a href="#app1-jcm-13-06197" class="usa-link">Supplementary Materials</a>). This is a multivariate reduction technique used to identify common variations across correlated variables to select the main components (latent variables) that explain most of the variation across the original data. The principal components (PCs) are new variables built as a combination of the original variables. The PCs are built in such a way that the first PC explains most of the variation of the data, the second PC is uncorrelated with the first one and explains the variations not accounted for by the first PC, and so on. The aim is to identify which components explain most of the variations of all data with the minimum number of PCs. Those PCs that explain most of the variation are retained for further analysis, while those that do not explain a lot of the variation are discarded. To decide on which PCs were relevant, we used the Kayser criterion and selected PCs with an eigenvalue of ≥1 [<a href="#B9-jcm-13-06197" class="usa-link" aria-describedby="B9-jcm-13-06197">9</a>]. Furthermore, we used the score distribution of each PC to categorize them into quantiles (<a href="#app1-jcm-13-06197" class="usa-link">Figure S1</a>). The aim was to assign the participants to the highest quantiles (Q3–Q4) or lower quantiles (Q1–Q2). Individuals in the highest quantile will have more of (or a combination of) the relevant symptoms than those in the lower quantiles. This implies that individuals occupying the upper quantiles are more likely to have a combination of clinical symptoms that are indicative of the severe end of the clinical spectrum.</p>
<p>For this analysis, we defined the clinical symptoms as ‘0’ and ‘1’ to denote the absence or presence of symptoms, respectively. PCA was carried out using matrix correlations on complete cases and using varimax rotation, wherein the residual correlation between latent components is not assumed. The above analysis was performed using SPSS for Windows, version 21.0 (SPSS; Chicago, IL, USA). Furthermore, we compared the quantile distribution of the PCs (Q1; Q2; Q3; Q4) according to their demographic and genetic characteristics. Overall differences in the observed versus the expected distribution (counts of participants per quantile) of the participants for each PC across quantiles per category (e.g., gender; family history of PNP) were determined using chi-square tests. Post hoc analysis was performed when the chi-square value was significant (<em>p</em>-value ≤ 0.05) to analyze which group was leading the deviation in the observed–expected distribution of counts. Significant deviations were considered significant with an adjusted <em>p</em>-value of ≤0.05.</p>
<p>For the genetic analysis, we considered individuals to be either <em>TTR</em>-positive or negative (see <a href="#sec2dot4-jcm-13-06197" class="usa-link">Section 2.4</a>, Genetic Testing). We also compared <em>TTR</em>-specific P/LP variants with the new PC components. Subjects with VUS were not included in the analysis, due to the uncertain functional and clinical impacts of the variants and the low number that was detected (only 4 participants).</p>
<p>Sensitivity analysis was performed to compare the main demographic and clinical characteristics (using the main PCs). Participants with confirmed ATTRwt amyloidosis (inclusion criteria: ‘suspicion of ATTRwt amyloidosis, based on imaging or biopsy’ and being genetically TTR-negative, <em>n</em> = 503) and participants with the clinical suspicion of hATTR and who were TTR-positive (<em>n</em> = 92) were included in this analysis.</p></section><section id="sec4-jcm-13-06197"><h2 class="pmc_sec_title">4. Results</h2>
<section id="sec4dot1-jcm-13-06197"><h3 class="pmc_sec_title">4.1. Description of the Cohorts</h3>
<p><a href="#jcm-13-06197-t001" class="usa-link">Table 1</a> presents the characteristics of the dataset and the two cohorts. Cohort 1 consisted of 2518 individuals and cohort 2 consisted of 649 participants. The participants of cohort 2 were slightly younger, with a median age of 64 years (inter-quantile range: 53–75 years old) compared to cohort 1, with a median age of 68 years (inter-quantile range: 56–79 years). In both cohorts, there were more males than females (66% and 64% males in cohort 1 and cohort 2, respectively), but there were no significant differences in the proportion of females between cohorts. Most of the participants were of European ancestry (97% and 94%) with a significantly higher proportion of these in Cohort 2. More than half of the participants were overweight or obese, with an increased proportion of them in Cohort 2. There was a significant difference in the proportion of men in the overweight group, with an under-representation in the underweight and normal weight groups (<a href="#app1-jcm-13-06197" class="usa-link">Supplementary Figure S2</a>; chi-square test: 111.01, df = 3, <em>p</em>-value &lt; 2.2 × 10<sup>−16</sup>).</p>
<section class="tw xbox font-sm" id="jcm-13-06197-t001"><h4 class="obj_head">Table 1.</h4>
<div class="caption p"><p>Demographic characteristics of the participants from the TRAMmoniTTR study.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Characteristics </th>
<th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Cohort 1 (<em>n</em> = 2518) </th>
<th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Cohort 2 (<em>n</em> = 649)</th>
<th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
<em>p</em>-Value <br>Cohort 1 vs. Cohort 2</th>
<th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Total (<em>n</em> = 3167)</th>
</tr></thead>
<tbody>
<tr>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<strong>Median age in years (IQ)</strong>
</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">68 (56–79) </td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">64 (53–75) </td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">67 (55–78)</td>
</tr>
<tr>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<strong>Missing</strong>
</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">35</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">35</td>
</tr>
<tr>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<strong>SEX</strong>
</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.07</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
</tr>
<tr>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<strong>Males</strong>
</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1663 (65.5%) </td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">424 (63.7%) </td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2087 (65.9%)</td>
</tr>
<tr>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<strong>Females</strong>
</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">853 (33.6%) </td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">224 (33.6%) </td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1077 (34%)</td>
</tr>
<tr>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<strong>Missing</strong>
</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2 (0.8%) </td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1 (0.2%) </td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3 (0.1%)</td>
</tr>
<tr>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<strong>ETHNICITY</strong>
</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.006</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
</tr>
<tr>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<strong>European ancestry *</strong>
</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2470 (97.4%) </td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">626 (94%) </td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3095 (97.7%)</td>
</tr>
<tr>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<strong>Other</strong>
</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">48 (1.9%) </td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">22 (6%) </td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">69 (2.2)</td>
</tr>
<tr>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<strong>Median BMI</strong>
</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">26.0 (23.5–29.2) </td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">26.3 (23.7–30.2) </td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.07</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">26.03 (23.5–29.4)</td>
</tr>
<tr>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<strong>BMI Categories *</strong>
</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.006</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
</tr>
<tr>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<strong>Underweight</strong>
</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">60 (2.4%) </td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8 (1.2%) </td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">68 (2.2%)</td>
</tr>
<tr>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<strong>Normal weight</strong>
</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">988 (39.2%) </td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">233 (35.9%) </td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1221 (38.6%)</td>
</tr>
<tr>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<strong>Overweight</strong>
</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">938 (37.3%) </td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">235 (35.2%) </td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1173 (37%)</td>
</tr>
<tr>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<strong>Obese</strong>
</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">508 (20.2%) </td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">167 (25.7%) </td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">675 (21.3%)</td>
</tr>
<tr>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<strong>Missing</strong>
</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">24 (1.0%) </td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6 (0.9%) </td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">30 (0.9%)</td>
</tr>
<tr>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<strong>Age at onset of polyneuropathy; Median *</strong>
</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N = 1216; 56 (48–68) </td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N = 390; 55 (45–65) </td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.39</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N = 1606; 56 (47–67)</td>
</tr>
<tr>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<strong>Age at diagnosis of polyneuropathy; Median</strong>
</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N = 1188; 58 (50–70) </td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N = 386; 57 (48–68) </td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.08</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N = 1574; 59 (50–69)</td>
</tr>
<tr>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<strong>Age at onset of cardiomyopathy; Median (IQ)</strong>
</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N = 721; 71 (58–79) </td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N = 222; 65 (55–75) </td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N = 943; 70 (56–78)</td>
</tr>
<tr>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<strong>Age at diagnosis of cardiomyopathy; Median, (IQ)</strong>
</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N = 761; 73 (58–80) </td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N = 241; 66 (55–77) </td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N = 1002; 71 (57–80)</td>
</tr>
<tr>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<strong>Familial history of polyneuropathy *</strong>
</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
</tr>
<tr>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<strong>Yes</strong>
</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">232 (9.2%) </td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">60 (9.2%)</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">292 (9.2%)</td>
</tr>
<tr>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<strong>No</strong>
</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1526 (60.6%) </td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">458 (68%) </td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1984 (62.6%)</td>
</tr>
<tr>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<strong>Unknown</strong>
</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">755 (30%) </td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">127 (19%) </td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">888 (27.8%)</td>
</tr>
<tr>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<strong>Missing</strong>
</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5 (0.2%) </td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4 (0.6%) </td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9 (0.3%)</td>
</tr>
<tr>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<strong>Familial history of cardiomyopathy *</strong>
</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
</tr>
<tr>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<strong>Yes</strong>
</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">226 (9.0%) </td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">67 (10.3%) </td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">293 (9.3%)</td>
</tr>
<tr>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<strong>No</strong>
</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1452 (58%) </td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">427 (65.8%) </td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1879 (59.3%)</td>
</tr>
<tr>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<strong>Unknown</strong>
</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">836 (33.2%) </td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">151 (23.3%) </td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">987 (31.2%)</td>
</tr>
<tr>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<strong>Missing</strong>
</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4 (0.2%) </td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4 (0.6%) </td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8 (0.3%)</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/jcm-13-06197-t001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="fn5"><p><em>p</em>-values were derived with the chi-squared test or Mann–Whitney tests (see <a href="#sec2-jcm-13-06197" class="usa-link">Section 2</a>). <em>p</em>-values of &lt;0.05 were considered statistically significant.</p></div></div></section><p>Approximately 50% of the participants could give a recorded age for onset and an age at diagnosis of either CM or PNP. The age of onset and diagnoses of PNP were similar in both cohorts, with a median age of 59 years (IQR: 50–59 years). Participants from cohort 1 had a significantly later age of onset and diagnosis of CM (onset at 71 years (58–79) vs. 65 (55–75)) (<a href="#jcm-13-06197-t001" class="usa-link">Table 1</a>). In both cohorts, the time that elapsed between the onset and diagnosis of CM or PNP was approximately 2 years. The proportion of participants with a familial history of CM or PNP was low, with a similar proportion in both cohorts (9% and 10%, <a href="#jcm-13-06197-t001" class="usa-link">Table 1</a>).</p>
<p>In cohort 1, the largest group of participants had a clinical history of PNP (1477 out of 2537; 58% of participants), while 1038 (of 2537; 41%) had CM and 278 (11%) had both. Such information regarding cohort 2 was unavailable.</p></section><section id="sec4dot2-jcm-13-06197"><h3 class="pmc_sec_title">4.2. Clinical Manifestations</h3>
<p>Following the previous study by Skrahina et al. [<a href="#B8-jcm-13-06197" class="usa-link" aria-describedby="B8-jcm-13-06197">8</a>], we estimated the prevalence of symptoms associated with PNP and CM (<a href="#jcm-13-06197-f001" class="usa-link">Figure 1</a>). In cohort 1, the most common symptoms included tingling and numbness (67%), fatigue (47%), and weakness (45%), and less common symptoms included a loss of smell (6%) and enlargement of the heart (1%). In cohort 2 the main symptoms were: pain, tingling, and numbness present in over 50% of participants. Less common symptoms included anemia (10%), bouts of constipation and diarrhea (10%), and erection problems (75% of men).</p>
<figure class="fig xbox font-sm" id="jcm-13-06197-f001"><h4 class="obj_head">Figure 1.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=11508262_jcm-13-06197-g001.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a720/11508262/d1a99d453331/jcm-13-06197-g001.jpg" loading="lazy" height="410" width="789" alt="Figure 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/jcm-13-06197-f001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Frequency bar-plot of the main symptoms of participants from the two cohorts described in TRAMmoni<em>TTR</em> study 1.</p></figcaption></figure><p>Cohort 1 consists of 2518 participants from the TRAMmoniTTR study and cohort 2 consists of 649 participants from the TRAM study.</p>
<p>To understand the underlying physiopathology of the clinical symptoms in participants from the TRAMmoni<em>TTR</em> study, we performed a PCA using the shared symptoms in both cohorts. Out of the shared 22 individual symptoms, we excluded the HPO term ‘enlarged heart muscle’ since it was reported in few participants from cohort 1. In addition, we excluded the HPO term ‘difficulty in getting an erection’, since this was only restricted to men.</p>
<p>Details of the PCA analysis are presented in the Supplementary Results (<a href="#app1-jcm-13-06197" class="usa-link">Table S2</a>: Descriptive statistics of main symptoms used for PCA), <a href="#app1-jcm-13-06197" class="usa-link">Table S3</a> (KMO and Bartlett’s test, used to assess whether PCA was appropriate for the dataset). In the factor analysis, we identified five main variables (hereafter principal components—PCs; eigenvalue &gt; 1) that explained up to 49% of the common variation in the symptoms in the 2345 cases with complete data (<a href="#jcm-13-06197-t002" class="usa-link">Table 2</a>; <a href="#app1-jcm-13-06197" class="usa-link">Table S4</a>). Looking at the correlation coefficients between individual symptoms and the identified clusters showed us that there was a high correlation between the first PC and polyneuropathy-associated symptoms, including the dysregulation of temperature (0.75), the sensation of burning feet (0.73), allodynia (0.66), numbness/tingling (0.66), and dyshidrosis (0.44). We labeled this component as polyneuropathy-related (PC-NP, <a href="#jcm-13-06197-t002" class="usa-link">Table 2</a>). The second PC was dominated by cardiovascular symptoms, including palpitations (0.81), heartbeat problems (0.71), and shortness of breath (0.62), with moderate correlations with chest pain (0.52), and a weak correlation was detected with water retention in the ankles and limbs (0.36). We labeled this component as cardiomyopathy-related (PC-CM; <a href="#jcm-13-06197-t002" class="usa-link">Table 2</a>). The third variable was labeled as a gastrointestinal component (PC-GI; <a href="#jcm-13-06197-t002" class="usa-link">Table 2</a>) with high correlations for constipation (0.65), diarrhea (0.74), or bouts of diarrhea or constipation (0.82), and a weak correlation with difficulty in holding back urine (0.36). General complaints (PC-GC) were correlated with unintended weight loss (0.75) and anemia (0.68). Finally, carpal tunnel syndrome (PC-CT) was mostly dominated by this pathology (0.79) and water retention in the ankles and limbs (0.53).</p>
<section class="tw xbox font-sm" id="jcm-13-06197-t002"><h4 class="obj_head">Table 2.</h4>
<div class="caption p"><p>Main variables identified after factor analysis. Five main PCs were identified. The values in the cells are the correlation coefficients between individual symptoms and the main PC identified.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</th>
<th colspan="5" align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Principal Component (PC)</th>
</tr>
<tr>
<th align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</th>
<th align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Polyneuropathy (PC-PN)</th>
<th align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cardiomyopathy (PC-CM)</th>
<th align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Gastrointestinal (PC-GI)</th>
<th align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">General Complaints (PC-GP)</th>
<th align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Carpal Tunnel Synd. (PC-CT)</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<strong>Carpal tunnel</strong>
</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.003</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.007</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.043</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">−0.049</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<strong>0.793</strong>
</td>
</tr>
<tr>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<strong>Water retention: ankle, limbs</strong>
</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">−0.041</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.358</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.038</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.198</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.533</td>
</tr>
<tr>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<strong>Shortness of breath</strong>
</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">−0.224</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<strong>0.623</strong>
</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.022</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.125</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.305</td>
</tr>
<tr>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<strong>Difficulty in holding back urine</strong>
</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.139</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.059</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.362</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.070</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.262</td>
</tr>
<tr>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<strong>Numbness or tingling</strong>
</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<strong>0.667</strong>
</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">−0.174</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.068</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.003</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.257</td>
</tr>
<tr>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<strong>Burning feet</strong>
</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<strong>0.726</strong>
</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">−0.055</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.074</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">−0.061</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.110</td>
</tr>
<tr>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<strong>Chest pain</strong>
</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">−0.019</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.518</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.146</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">−0.122</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.087</td>
</tr>
<tr>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<strong>Constipation</strong>
</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.079</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.056</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<strong>0.667</strong>
</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.067</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.067</td>
</tr>
<tr>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<strong>Anemia</strong>
</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">−0.030</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.128</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.020</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<strong>0.678</strong>
</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.064</td>
</tr>
<tr>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<strong>Heartbeat alterations</strong>
</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.014</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<strong>0.717</strong>
</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.037</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.151</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.031</td>
</tr>
<tr>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<strong>Unintended weight loss</strong>
</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.020</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">−0.054</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.123</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<strong>0.747</strong>
</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.017</td>
</tr>
<tr>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<strong>Dizziness</strong>
</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.219</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.288</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.238</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.227</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.009</td>
</tr>
<tr>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<strong>Allodynia</strong>
</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<strong>0.630</strong>
</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.067</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.047</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">−0.014</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">−0.124</td>
</tr>
<tr>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<strong>Sensing temperature alterations</strong>
</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<strong>0.752</strong>
</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">−0.064</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.031</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">−0.029</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">−0.083</td>
</tr>
<tr>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<strong>Palpitations</strong>
</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.028</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<strong>0.809</strong>
</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.047</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.003</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">−0.079</td>
</tr>
<tr>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<strong>Dyshidrosis</strong>
</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.410</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.108</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.178</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.185</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">−0.073</td>
</tr>
<tr>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<strong>Constipation/diarrhea bouts</strong>
</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.088</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.083</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<strong>0.833</strong>
</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">−0.011</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">−0.034</td>
</tr>
<tr>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<strong>Diarrhea</strong>
</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.033</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.080</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<strong>0.753</strong>
</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.079</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">−0.020</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/jcm-13-06197-t002/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="fn6"><p>Robust correlations (&gt;0.6) between individual symptoms and PC are presented in bold.</p></div></div></section><p>We used the quantile distribution of the PCs to analyze the data. <a href="#app1-jcm-13-06197" class="usa-link">Figure S1</a> presents the score distribution for four main PCs, alongside the participants per quantile. This comparison allowed the evaluation of the observed number of individuals per quantile (<a href="#sec2-jcm-13-06197" class="usa-link">Section 2</a>, Materials and Methods) with other demographic characteristics and focused on the four main PCs.</p>
<p>We found significant differences between gender and PC-NP, PC-CM, and PC-GI, with an over-representation of men in the higher quantiles of PC-NP (relative to the lower quantiles; <a href="#app1-jcm-13-06197" class="usa-link">Table S6</a>; chi-squared <em>p</em>-value = 5 × 10<sup>−12</sup>), while the opposite result was found for women. This means that more men were in the more severe clinical spectrum of PNP while women tended to be at the milder end of the spectrum.</p>
<p>In addition, there was an under-representation of men in the lowest quantiles for PC-CM (chi-squared <em>p</em>-value = 4.893 × 10<sup>−12</sup>).</p>
<p>We also found significant differences when comparing participants with PNP regarding their family history of PNP. Overall, we found that among the participants in the group with a positive family history, there was a higher number (than expected) of participants at the mild end of the clinical spectrum, with a trend toward a lower number of participants at the more severe end of the spectrum (<a href="#app1-jcm-13-06197" class="usa-link">Table S6</a>). Similarly, we detected significant differences when comparing participants with CM and their family history of this disorder. Among patients with a positive family history of CM, there was an over-representation of participants at the milder end of the CM clinical spectrum (<a href="#app1-jcm-13-06197" class="usa-link">Table S6</a>). This could suggest that having a positive family history leads to earlier disease recognition.</p></section><section id="sec4dot3-jcm-13-06197"><h3 class="pmc_sec_title">4.3. Genetic Analysis</h3>
<p>After sequencing analysis of the <em>TTR</em> gene in all participants, we detected that 3% of the participants (<em>n</em> = 92/3206) were positive for heterozygous P/LP variants in <em>TTR</em>. We identified 17 different missense variants. Of these, the most common variant was c.148G&gt;A p.Val50Met, which was present in 42% of the participants who were positive for <em>TTR</em> variants. The second most frequent variant was c.424G&gt;A p.Val142Ile (hereafter: p.Val142Ile), which was present in 13%, followed by c.311T&gt;C p.Ile104Thr (hereafter: p.Ile104Thr), which was present in 9% of the <em>TTR</em>-positive participants. The remaining variants were found in fewer than nine participants (<a href="#jcm-13-06197-t003" class="usa-link">Table 3</a>). There were only four VUS reported: c.280G&gt;C p.Asp94His [<a href="#B10-jcm-13-06197" class="usa-link" aria-describedby="B10-jcm-13-06197">10</a>]; c.386C&gt;T p.Ala129Val [<a href="#B11-jcm-13-06197" class="usa-link" aria-describedby="B11-jcm-13-06197">11</a>]; c.310A&gt;G p.Ile104Val; and c.427A&gt;G p.Thr143Ala. The last two variants are novel and ultra-rare and are reported for the first time in this study, with no occurrences in gnomAD.</p>
<section class="tw xbox font-sm" id="jcm-13-06197-t003"><h4 class="obj_head">Table 3.</h4>
<div class="caption p"><p>Relevant TTR variants identified in the TRAMmoni<em>TTR</em> study (<a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000371.3" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000371.3</a>).</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">HGVS-cDNA</th>
<th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">HGVS-Protein</th>
<th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Variant Classification</th>
<th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Allele Count (All Are Heterozygous)</th>
<th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Frequency</th>
</tr></thead>
<tbody>
<tr>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<strong>c.148G&gt;A</strong>
</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">p.Val50Met</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pathogenic</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">39</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">42.39</td>
</tr>
<tr>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<strong>c.424G&gt;A</strong>
</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">p.Val142Ile</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pathogenic</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">13.04</td>
</tr>
<tr>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<strong>c.311T&gt;C</strong>
</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">p.Ile104Thr</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pathogenic</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9.78</td>
</tr>
<tr>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<strong>c.238A&gt;G</strong>
</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">p.Thr80Ala</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pathogenic</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6.52</td>
</tr>
<tr>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<strong>c.379A&gt;G</strong>
</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">p.Ile127Val</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pathogenic</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.43</td>
</tr>
<tr>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<strong>c.424G&gt;C</strong>
</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">p.Val142Leu</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Likely pathogenic</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.43</td>
</tr>
<tr>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<strong>c.88T&gt;C</strong>
</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">p.Cys30Arg</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pathogenic</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.35</td>
</tr>
<tr>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<strong>c.118G&gt;A</strong>
</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">p.Val40Ile</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pathogenic</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.17</td>
</tr>
<tr>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<strong>c.341T&gt;C</strong>
</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">p.Val114Ala</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pathogenic</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.17</td>
</tr>
<tr>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<strong>c.193G&gt;A</strong>
</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">p.Ala65Thr</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Likely pathogenic</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.09</td>
</tr>
<tr>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<strong>c.224T&gt;G</strong>
</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">p.Leu75Arg</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pathogenic</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.09</td>
</tr>
<tr>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<strong>c.280G&gt;C</strong>
</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">p.Asp94His</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Uncertain Significance</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.09</td>
</tr>
<tr>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<strong>c.310A&gt;G</strong>
</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">p.Ile104Val</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Uncertain Significance</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.09</td>
</tr>
<tr>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<strong>c.325G&gt;A</strong>
</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">p.Glu109Lys</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pathogenic</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.09</td>
</tr>
<tr>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<strong>c.377C&gt;A</strong>
</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">p.Thr126Asn</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Likely Pathogenic</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.09</td>
</tr>
<tr>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<strong>c.386C&gt;T</strong>
</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">p.Ala129Val</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Uncertain Significance</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.09</td>
</tr>
<tr>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<strong>c.427A&gt;G</strong>
</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">p.Thr143Ala</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Uncertain Significance</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.09</td>
</tr>
<tr>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<strong>Total</strong>
</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<strong>92</strong>
</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">100</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/jcm-13-06197-t003/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="fn7"><p>HGVS nomenclature (Human Genome Variation Society).</p></div></div></section><p>We tested for differences in the number of participants at different quantiles of the main PCs and TTR-positive (hATTR = 92) and TTR-negative participants (ATTRwt = 503). We found differences in <em>TTR</em> status and the PC-GI (chi-squared test: 9.3; 3 df; <em>p</em>-value = 0.026), with a tendency to a lower proportion of <em>TTR</em>-positive individuals in the highest quantile (<a href="#app1-jcm-13-06197" class="usa-link">Table S6</a>). Thus, participants with hATTR were less likely to have severe GI symptoms. We also found borderline differences per gender and BMI categories in hATTR vs. ATTRwt participants (chi-square test: 3.68; 1 df; <em>p</em>-value = 0.06 for gender), with a higher proportion of males in the hATTR group, although this was not significant after correcting for multiple testing. For the BMI groups, we found a borderline significance difference in <em>TTR</em>-positive status (chi-squared: 7.4783, df = 3, <em>p</em>-value = 0.06 for BMI categories), with an over-representation of hATTR in the overweight group, although this was not statistically significant in the post hoc analysis.</p>
<p>Furthermore, we selected only <em>TTR</em>-positive subjects (hATTR) and compared whether there were differences in the demographics or clinical characteristics of subjects with specific P/LP variants. Given the low prevalence of <em>TTR</em> P/LP variants, we focused on the most frequent variant (p.Val50Met; heterozygotes labeled as 1, <em>n</em> = 39; no-Val50Met, labeled as 0, <em>n</em> = 49). Looking at the main PC variables, there was a significant difference in the number of individuals positive and negative for this variant (chi-squared test = 10.1, df = 3, and <em>p</em>-value = 0.02) (<a href="#jcm-13-06197-f002" class="usa-link">Figure 2</a>), with a borderline-significant over-representation of p.Val50Met heterozygotes in the highest quantiles of the PC-CM (Q3-CM, <em>p</em>-value = 0.06). Looking at the specific symptoms represented in PC-CM showed an excess of p.Val50Met heterozygotes in participants who reported heartbeat alterations (Fisher’s exact test; <em>p</em>-value = 0.05; data not shown).</p>
<figure class="fig xbox font-sm" id="jcm-13-06197-f002"><h4 class="obj_head">Figure 2.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=11508262_jcm-13-06197-g002.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a720/11508262/be1e6c5fd24a/jcm-13-06197-g002.jpg" loading="lazy" height="405" width="710" alt="Figure 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/jcm-13-06197-f002/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Distribution of TTR p.Val50Met heterozygotes and TTR+ without the p.Val50Met variant per quantile (1–4) of the main principal components (PC).</p></figcaption></figure><p>The graph presents the proportion of participants that were heterozygous for the p.Val50Met variants (labeled as 1) versus TTR+ participants without the p.Val50Met variant (labeled as 0), according to the main principal component of the study, namely, the polyneuropathy (PN), cardiomyopathy (CM), gastrointestinal (GI), and general symptoms (GS) components.</p>
<p>Finally, we compared the demographic and clinical characteristics of participants with hATTR (<em>TTR</em>-positive) and participants with ATTRwt (<em>TTR</em>-negative and also meeting the inclusion criteria for ‘suspicion of amyloidosis, based on imaging or biopsy’). We found a significantly increased number of men in the ATTRwt group compared with the hATTR group (<a href="#app1-jcm-13-06197" class="usa-link">Table S7</a>). From these analyses, we concluded that there was an over-representation of hATTR patients in the lower clinical spectrum of PNP, with an opposite effect seen in the ATTRwt group. In addition, there were fewer than expected hATTR patients in the lower clinical spectrum of CM, compared to the ATTRwt group, which had more than the expected number of patients in the lower CM clinical spectrum.</p>
<p>Furthermore, there was a significant over-representation of hATTR participants with a positive family history of CM (chi-square = 64.8; df = 3; <em>p</em>-value = 8.024 × 10<sup>−16</sup>) and PNP (81.60; <em>p</em>-value &lt; 2.2 × 10<sup>−16</sup>) (<a href="#app1-jcm-13-06197" class="usa-link">Supplementary Table S6</a>), as expected, given the autosomal dominant inheritance of the disorder.</p></section></section><section id="sec5-jcm-13-06197"><h2 class="pmc_sec_title">5. Discussion</h2>
<p>For this study, we described the main demographic and clinical characteristics of 3167 study participants who were at risk of hATTR amyloidosis, as part of the TRAMmoni<em>TTR</em> study, which included <em>TTR</em> genetic testing of this at-risk population. Over half of the participants of this study were men who were overweight or obese (<a href="#app1-jcm-13-06197" class="usa-link">Supplementary Figure S1</a>), who presented with symptoms consistent with PNP (59%). Genetic analysis of <em>TTR</em> showed that 3% of the participants had P/LP variants, with p.Val50Met, p.Val142Ile, and p.Ile104Thr being the most prevalent (42%, 11%, and 9%, respectively). We also identified two novel variants (of unknown significance—VUS); c.310A&gt;G p.Ile104Val and c.427A&gt;G p.Thr143Ala have not been described previously in the literature or in public databases.</p>
<p>The demographic characteristics of the present study (<em>n</em> = 3167 participants from cohort 1 and cohort 2) were in line with the previous TRAM study, with the disease being more prevalent in men than in women (66% males in the TRAMmoni<em>TTR</em> study vs. 62% of males in the TRAM study). The median age of the participants in the current study was 67 years (IQR: 55–78, TRAMmoni<em>TTR</em> study) vs. 61 years (IQR: 18–85) in the TRAM study. The demographic characteristics in this work were also similar to the THAOS study, although the proportion of men in the THAOS study was much larger (70%) and included a wider range of participants from different countries [<a href="#B7-jcm-13-06197" class="usa-link" aria-describedby="B7-jcm-13-06197">7</a>].</p>
<p>Clinically speaking, from the total of 2537 participants with a clinical history of PNP and/or CM, 58% presented with PNP, 41% presented with CM, and 11% presented with both. Previously reported studies showed a variable frequency of PNP (THAOS 64%, TRAM 23.8%) [<a href="#B8-jcm-13-06197" class="usa-link" aria-describedby="B8-jcm-13-06197">8</a>,<a href="#B12-jcm-13-06197" class="usa-link" aria-describedby="B12-jcm-13-06197">12</a>]. CM was reported at low frequency among THAOS subjects (14.9%) compared to TRAM (55.4%), while the frequency of combined PNP and CM was similar in both studies (21.1% and 20.8%) [<a href="#B8-jcm-13-06197" class="usa-link" aria-describedby="B8-jcm-13-06197">8</a>,<a href="#B12-jcm-13-06197" class="usa-link" aria-describedby="B12-jcm-13-06197">12</a>]. Differences in the frequency of PNP, CM, and combined phenotypes are likely due to the participants’ geographical origin and the inclusion criteria. The THAOS report included 1411 symptomatic subjects from nine continental Western European countries [<a href="#B12-jcm-13-06197" class="usa-link" aria-describedby="B12-jcm-13-06197">12</a>], with a large proportion of patients from Portugal, where the disease is considered to be endemic. In addition, it has been suggested that the decreased proportion of CM patients in the THAOS study could be due to bias in the diagnostic assessment process, which included more neurology specialists in Portugal [<a href="#B13-jcm-13-06197" class="usa-link" aria-describedby="B13-jcm-13-06197">13</a>]. In contrast, the TRAM study included 5141 participants who enrolled in Germany, Austria, and Switzerland [<a href="#B8-jcm-13-06197" class="usa-link" aria-describedby="B8-jcm-13-06197">8</a>], with the involvement of both neurological and cardiovascular specialists across the recruitment centers.</p>
<p>Historically, ATTR amyloidosis has been classified as ATTR-PNP, ATTR-CM, or a mixture of both phenotypes, depending on the clinical features and the results from diagnostic tests. In the current study, we applied PCA to cluster single symptoms into main groups to enable genotype–phenotype analyses. In this data-driven analysis, these two main phenotypes were also retrieved. Moreover, we identified a third component of mostly gastrointestinal symptoms. This component encompassed the clinical symptoms of diarrhea and/or constipation (<a href="#jcm-13-06197-t002" class="usa-link">Table 2</a>). Since PCA is data-specific, it is not clear whether these other components will be relevant in other clinical cohorts. However, the fact that we retrieved the first two main components serves as a first validation for these analyses.</p>
<p>The prevalence of the <em>TTR</em> P/LP variants was higher in our study (3%), most likely due to the current inclusion criteria (one criterion was being diagnosed with hATTR amyloidosis—see <a href="#sec2-jcm-13-06197" class="usa-link">Section 2</a>). Similar to other studies, the most frequent pathogenic variant was p.Val50Met, with a prevalence of 42%, which is higher than in previously reported studies (pooled prevalence 33%; confidence interval: 16–56; Delgado D et al., November 2023, 4th International Congress of ATTR Amyloidosis). This variant has been associated with an increased prevalence of PNP and the earlier onset of disease [<a href="#B2-jcm-13-06197" class="usa-link" aria-describedby="B2-jcm-13-06197">2</a>]. Here, we did not find any significant difference in the number of heterozygotes with p.Val50Met and PNP. Only a borderline difference was observed in male participants with CM (PC-CM), specifically, with alterations in heartbeat. The second most common variant was the p.Val142Ile, with a frequency of 13%, which was the second most frequent variant in the TRAM study (15%). In this study, the p.Ile104Thr was the third most frequent variant, with a frequency of almost 10% (9 participants). This variant has been reported in both German and British patients [<a href="#B14-jcm-13-06197" class="usa-link" aria-describedby="B14-jcm-13-06197">14</a>] and has been associated with CM [<a href="#B14-jcm-13-06197" class="usa-link" aria-describedby="B14-jcm-13-06197">14</a>]. Due to the low number of participants with this variant, it was not possible to correlate this with other demographic characteristics. In the previous TRAM analysis, this variant had a lower prevalence of 4% (2/55 <em>TTR</em>-positive patients). The difference in the prevalence of these variants may be related to regional differences.</p>
<p>We found borderline correlations between sex and presenting more symptoms of PNP with an increased proportion of men in the highest quantile of PNP (PC-NP), and with women having fewer CM and GI symptoms than men (<a href="#jcm-13-06197-t003" class="usa-link">Table 3</a>). We also found that participants with hATTR were less likely to have severe GI symptoms (<a href="#app1-jcm-13-06197" class="usa-link">Supplementary Table S6</a>). This contrasts with previous reports wherein a higher prevalence of GI symptoms in patients with hATTR was reported [<a href="#B15-jcm-13-06197" class="usa-link" aria-describedby="B15-jcm-13-06197">15</a>,<a href="#B16-jcm-13-06197" class="usa-link" aria-describedby="B16-jcm-13-06197">16</a>]. The clinical presentation of GI may differ in each study, making the comparisons challenging. In general, the prevalence of GI symptoms may be lower, as shown by a recent literature review [<a href="#B17-jcm-13-06197" class="usa-link" aria-describedby="B17-jcm-13-06197">17</a>]. Further studies harmonizing the prevalence of GI symptoms may be required to validate our observations.</p>
<p>Finally, participants with a positive familial history of PNP or CM were significantly more likely to have PNP, CM, and GI symptoms themselves. The prevalence of hATTR (3%) in the TRAMmoni<em>TTR</em> study showed that most participants either had ATTRwt amyloidosis (20%; 503/2518 from cohort 1) or other types of PNP or CM. Having a positive family history of CM or PNP is a strong indicator of hATTR, and genetic TTR testing should be systematically offered to this group of patients.</p>
<p>The analysis of the hATTR and ATTRwt participants in this study showed a higher proportion of men in the latter group. Importantly, the hATTR group had a similar number of men/women. Regarding their clinical presentation, there was an excess of hATTR patients with few PNP symptoms, with an opposite effect seen in the ATTRwt group. This could imply that at least a group of participants with the inherited or genetic form of ATTR are detected earlier. Diagnosing ATTR amyloidosis presents challenges, as cardiac symptoms may mimic those of more common heart conditions. Traditionally, diagnosis required an invasive and costly endomyocardial biopsy, although this requirement has changed recently with the introduction of non-invasive techniques including scintigraphy in 2010 [<a href="#B18-jcm-13-06197" class="usa-link" aria-describedby="B18-jcm-13-06197">18</a>], as well as other echocardiographic techniques used to measure cardiac function. Indeed, in recent publications, it has been shown that measuring both atrial and ventricular cardiac work can help distinguish between the different types of hypertrophic cardiomyopathies [<a href="#B19-jcm-13-06197" class="usa-link" aria-describedby="B19-jcm-13-06197">19</a>,<a href="#B20-jcm-13-06197" class="usa-link" aria-describedby="B20-jcm-13-06197">20</a>]. In addition, cardiac magnetic resonance has been used to assess the degree and distribution of cardiac hypertrophy and could also help in the differential diagnosis of hypertrophic cardiomyopathy [<a href="#B21-jcm-13-06197" class="usa-link" aria-describedby="B21-jcm-13-06197">21</a>].</p>
<p>Still, the broad range of symptoms observed in the participants at the time of enrollment highlights the necessity of a multidisciplinary approach to managing all types of ATTR amyloidosis [<a href="#B2-jcm-13-06197" class="usa-link" aria-describedby="B2-jcm-13-06197">2</a>]. Our results seem to indicate a short time window of 2 years between the onset of symptoms and diagnosis in Germany, compared to the THAOS registry, where a 4-year time window was observed [<a href="#B7-jcm-13-06197" class="usa-link" aria-describedby="B7-jcm-13-06197">7</a>]. According to this study, the average time to diagnosis after symptom onset was 2 years. The diagnosis of ATTR amyloidosis is frequently delayed by several years. However, as shown in this study, genetic testing in participants with suspected ATTR amyloidosis and a positive family history of PNP or CM will help to distinguish those with the hereditary form of the disease.</p>
<p>One of the study’s strengths is the large sample size and the homogeneous ethnicity of the participants, which allows for the assessment of clinical symptoms and the presence of the relevant <em>TTR</em> variants in participants with suspected amyloidosis in an unbiased way. The main phenotypes identified were based purely on statistical analysis and, thus, allowed us to identify other components not currently being considered in other studies. Despite the large sample size, our study is still underpowered for conducting a more comprehensive analysis among hATTR participants and their clinical phenotypes. A meta-analysis of clinical cohorts will be necessary to further assess the phenotype– genotype correlations. Another possible limitation is that the inclusion criteria did not consider deeper phenotyping on neuropathy-related signs such as tendon tenosynovial involvement or lumbar stenosis. Likewise, classifications for cardiac hypertrophy according to the New York Heart Association were not available. Still, with our study, we were able to capture the main features associated with ATTR amyloidosis.</p></section><section id="sec6-jcm-13-06197"><h2 class="pmc_sec_title">6. Conclusions</h2>
<p>In this study, we detected a prevalence of 3% of hATTR and 20% of ATTRwt. <em>TTR</em> genetic testing should be offered to patients with clinical suspicion of amyloidosis and a family history of CM or PNP. The timely indication provided by genetic testing helped to shorten the diagnostic odyssey in this patient-screening program to roughly two years from symptom onset. This is a relevant achievement since specific treatments are available for both hATTR and ATTRwt [<a href="#B22-jcm-13-06197" class="usa-link" aria-describedby="B22-jcm-13-06197">22</a>]. Larger studies will need to be conducted to understand <em>TTR</em> genotype–phenotype correlations. The current clinical and genetic characterization of the cohort serves as a foundation for further longitudinal monitoring and assessment.</p></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgments</h2>
<p>We gratefully acknowledge Alnylam Germany GmbH for generously funding this study. Our sincere appreciation goes out to all the study participants for their invaluable contributions. Additionally, we extend our thanks to all principal investigators from the TRAM study (listed in <a href="#app1-jcm-13-06197" class="usa-link">Supplementary Table S1</a>) and their dedicated study-team members for their collaboration and support throughout the research process. We also thank Paulo Braga for providing useful comments on the manuscript.</p></section><section id="app1-jcm-13-06197" class="app"><h2 class="pmc_sec_title">Supplementary Materials</h2>
<p>The following supporting information can be downloaded at: <a href="https://www.mdpi.com/article/10.3390/jcm13206197/s1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.mdpi.com/article/10.3390/jcm13206197/s1</a>, Table S1: Centers participating in the study; Table S2: Descriptive statistics of the main symptoms used for PCA; Table S3: Test to assess whether the data are suitable for PCA; Table S4: Table presenting the proportion of the variance of the dataset explained by main PCs; Table S5: Descriptive statistics of the score distribution of the first four PCs; Table S6: Cross-table analysis comparing the ATTRwt and hATTR groups with the demographic and quantile distribution of four main PC scores; Figure S1: Score distribution of the first four main principal components (PCs); Figure S2: Plot representing the distribution of men and women according to BMI categories.</p>
<section class="sm xbox font-sm" id="jcm-13-06197-s001"><div class="media p"><div class="caption">
<a href="/articles/instance/11508262/bin/jcm-13-06197-s001.zip" data-ga-action="click_feat_suppl" class="usa-link">jcm-13-06197-s001.zip</a><sup> (558.7KB, zip) </sup>
</div></div></section></section><section id="notes1"><h2 class="pmc_sec_title">Author Contributions</h2>
<p>Conceptualization, formal analysis, writing original draft, writing—review and editing: S.R., L.M.P., A.M.B.-A., P.E., K.H. and P.B.; formal analysis: S.R., L.M.P. and A.M.B.-A.; investigation and methodology: V.S., A.R., S.S. (Sabine Schröder), S.Z. (Susanne Zielke), T.S., M.P., B.A., K.H., V.S. and A.R.; validation: S.R., V.B., J.K., G.W., F.R., S.S. (Snezana Skobalj), S.Z. (Susan Zielske), X.B., P.G. and J.R.; funding of the study: A.R.; drafting the manuscript; S.R., L.M.P., A.M.B.-A. and P.E.; final revision: all authors. All authors have read and agreed to the published version of the manuscript.</p></section><section id="notes2"><h2 class="pmc_sec_title">Institutional Review Board Statement</h2>
<p>The study was conducted in accordance with the Declaration of Helsinki, and approved by the Ethical Committee at the Medical Faculty of the University of Rostock (approval A 2018-0069, date: 24 April 2018). Ethics approval was obtained for each participating centre in Germany as detailed in the previous study [<a href="#B6-jcm-13-06197" class="usa-link" aria-describedby="B6-jcm-13-06197">6</a>].</p></section><section id="notes3"><h2 class="pmc_sec_title">Informed Consent Statement</h2>
<p>Informed consent was obtained from the referring physicians, patients, and/or their parents or legal guardians, including for the publication of anonymized individual details. The informed consent form is available in English and several other languages at: <a href="https://www.centogene.com/downloads.html" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.centogene.com/downloads.html</a> (accessed on 19 December 2023).</p></section><section id="notes4"><h2 class="pmc_sec_title">Data Availability Statement</h2>
<p>Data are available upon reasonable request. All data relevant to the study are included in the article or in the <a href="#app1-jcm-13-06197" class="usa-link">Supplementary Information</a>. The datasets supporting the current study are not public, due to data privacy laws for patients. Some data may be available upon request to the corresponding author.</p></section><section id="notes5"><h2 class="pmc_sec_title">Conflicts of Interest</h2>
<p>S.R., L.M.P., A.M.B.-A., P.E., S.S. (Sabine Schröder), S.Z. (Susanne Zielke), V.B., J.K., G.W., F.R., S.S. (Snezana Skobalj), S.Z. (Susan Zielske), X.B., P.G., J.R., and P.B. are (or were) employees of Centogene at the time of the design and execution of this study. K.H. received financial reimbursement for consulting, advisory board activities, speaker fees, and/or contributions to congresses and travel support to attend scientific meetings by Akcea Therapeuticals Inc., Alnylam Pharmaceuticals Inc., Amicus, AstraZeneca, GSK, Hormosan, Takeda Pharmaceutical Inc., Pfizer Pharmaceuticals Inc., Swedish Orphan Biovitrum Inc., and ViiV Healthcare GmbH. K.H. further received research funding by the foundation Charité (BIH clinical fellow), Alnylam Pharmaceuticals Inc., and Pfizer Pharmaceuticals. All authors declare no conflicts of interest pertaining to their contribution to this work.</p></section><section id="funding-statement1" lang="en"><h2 class="pmc_sec_title">Funding Statement</h2>
<p>The study was funded by Alnylam Pharmaceuticals Inc., Cambridge, MA, USA. The funders of this study had no role in the study design, data analysis, data interpretation, or writing of the manuscript.</p></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm"><div class="fn p" id="fn4"><p><strong>Disclaimer/Publisher’s Note:</strong> The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.</p></div></div></section><section id="ref-list1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="ref-list1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="B1-jcm-13-06197">
<span class="label">1.</span><cite>Ando Y., Coelho T., Berk J.L., Cruz M.W., Ericzon B.-G., Ikeda S.-I., Lewis W.D., Obici L., Planté-Bordeneuve V., Rapezzi C., et al.  Guideline of transthyretin-related hereditary amyloidosis for clinicians. Orphanet J. Rare Dis. 2013;8:31. doi: 10.1186/1750-1172-8-31.</cite> [<a href="https://doi.org/10.1186/1750-1172-8-31" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3584981/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23425518/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Orphanet%20J.%20Rare%20Dis.&amp;title=Guideline%20of%20transthyretin-related%20hereditary%20amyloidosis%20for%20clinicians&amp;author=Y.%20Ando&amp;author=T.%20Coelho&amp;author=J.L.%20Berk&amp;author=M.W.%20Cruz&amp;author=B.-G.%20Ericzon&amp;volume=8&amp;publication_year=2013&amp;pages=31&amp;pmid=23425518&amp;doi=10.1186/1750-1172-8-31&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B2-jcm-13-06197">
<span class="label">2.</span><cite>Poli L., Labella B., Piccinelli S.C., Caria F., Risi B., Damioli S., Padovani A., Filosto M. Hereditary transthyretin amyloidosis: A comprehensive review with a focus on peripheral neuropathy. Front. Neurol. 2023;14:1242815.  doi: 10.3389/fneur.2023.1242815.</cite> [<a href="https://doi.org/10.3389/fneur.2023.1242815" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10585157/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37869146/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front.%20Neurol.&amp;title=Hereditary%20transthyretin%20amyloidosis:%20A%20comprehensive%20review%20with%20a%20focus%20on%20peripheral%20neuropathy&amp;author=L.%20Poli&amp;author=B.%20Labella&amp;author=S.C.%20Piccinelli&amp;author=F.%20Caria&amp;author=B.%20Risi&amp;volume=14&amp;publication_year=2023&amp;pages=1242815&amp;pmid=37869146&amp;doi=10.3389/fneur.2023.1242815&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B3-jcm-13-06197">
<span class="label">3.</span><cite>Rowczenio D.M., Noor I., Gillmore J.D., Lachmann H., Whelan C., Hawkins P.N., Obici L., Westermark P., Grateau G., Wechalekar A.D. Online registry for mutations in hereditary amyloidosis including nomenclature recommendations. Hum. Mutat. 2014;35:E2403–E2412. doi: 10.1002/humu.22619.</cite> [<a href="https://doi.org/10.1002/humu.22619" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25044787/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hum.%20Mutat.&amp;title=Online%20registry%20for%20mutations%20in%20hereditary%20amyloidosis%20including%20nomenclature%20recommendations&amp;author=D.M.%20Rowczenio&amp;author=I.%20Noor&amp;author=J.D.%20Gillmore&amp;author=H.%20Lachmann&amp;author=C.%20Whelan&amp;volume=35&amp;publication_year=2014&amp;pages=E2403-E2412&amp;pmid=25044787&amp;doi=10.1002/humu.22619&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B4-jcm-13-06197">
<span class="label">4.</span><cite>Zhen D.B., Swiecicki P.L., Zeldenrust S.R., Dispenzieri A., Mauermann M.L., Gertz M.A. Frequencies and geographic distributions of genetic mutations in transthyretin- and non-transthyretin-related familial amyloidosis. Clin. Genet. 2015;88:396–400. doi: 10.1111/cge.12500.</cite> [<a href="https://doi.org/10.1111/cge.12500" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25211232/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin.%20Genet.&amp;title=Frequencies%20and%20geographic%20distributions%20of%20genetic%20mutations%20in%20transthyretin-%20and%20non-transthyretin-related%20familial%20amyloidosis&amp;author=D.B.%20Zhen&amp;author=P.L.%20Swiecicki&amp;author=S.R.%20Zeldenrust&amp;author=A.%20Dispenzieri&amp;author=M.L.%20Mauermann&amp;volume=88&amp;publication_year=2015&amp;pages=396-400&amp;pmid=25211232&amp;doi=10.1111/cge.12500&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B5-jcm-13-06197">
<span class="label">5.</span><cite>Hund E., Linke R.P., Willig F., Grau A. Transthyretin-associated neuropathic amyloidosis. Neurology. 2001;56:431–435. doi: 10.1212/WNL.56.4.431.</cite> [<a href="https://doi.org/10.1212/WNL.56.4.431" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11261421/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neurology&amp;title=Transthyretin-associated%20neuropathic%20amyloidosis&amp;author=E.%20Hund&amp;author=R.P.%20Linke&amp;author=F.%20Willig&amp;author=A.%20Grau&amp;volume=56&amp;publication_year=2001&amp;pages=431-435&amp;pmid=11261421&amp;doi=10.1212/WNL.56.4.431&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B6-jcm-13-06197">
<span class="label">6.</span><cite>Adams D., Koike H., Slama M., Coelho T. Hereditary transthyretin amyloidosis: A model of medical progress for a fatal disease. Nat. Rev. Neurol. 2019;15:387–404. doi: 10.1038/s41582-019-0210-4.</cite> [<a href="https://doi.org/10.1038/s41582-019-0210-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31209302/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Rev.%20Neurol.&amp;title=Hereditary%20transthyretin%20amyloidosis:%20A%20model%20of%20medical%20progress%20for%20a%20fatal%20disease&amp;author=D.%20Adams&amp;author=H.%20Koike&amp;author=M.%20Slama&amp;author=T.%20Coelho&amp;volume=15&amp;publication_year=2019&amp;pages=387-404&amp;pmid=31209302&amp;doi=10.1038/s41582-019-0210-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B7-jcm-13-06197">
<span class="label">7.</span><cite>Gentile L., Coelho T., Dispenzieri A., Conceição I., Waddington-Cruz M., Kristen A., Wixner J., Diemberger I., Gonzalez-Moreno J., Cariou E., et al.  A 15-year consolidated overview of data in over 6000 patients from the Transthyretin Amyloidosis Outcomes Survey (THAOS) Orphanet J. Rare Dis. 2023;18:350. doi: 10.1186/s13023-023-02962-5.</cite> [<a href="https://doi.org/10.1186/s13023-023-02962-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10636983/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37946256/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Orphanet%20J.%20Rare%20Dis.&amp;title=A%2015-year%20consolidated%20overview%20of%20data%20in%20over%206000%20patients%20from%20the%20Transthyretin%20Amyloidosis%20Outcomes%20Survey%20(THAOS)&amp;author=L.%20Gentile&amp;author=T.%20Coelho&amp;author=A.%20Dispenzieri&amp;author=I.%20Concei%C3%A7%C3%A3o&amp;author=M.%20Waddington-Cruz&amp;volume=18&amp;publication_year=2023&amp;pages=350&amp;pmid=37946256&amp;doi=10.1186/s13023-023-02962-5&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B8-jcm-13-06197">
<span class="label">8.</span><cite>Skrahina V., Grittner U., Beetz C., Skripuletz T., Juenemann M., Krämer H.H., Hahn K., Rieth A., Schaechinger V., Patten M., et al.  Hereditary transthyretin-related amyloidosis is frequent in polyneuropathy and cardiomyopathy of no obvious aetiology. Ann. Med. 2021;53:1787–1796. doi: 10.1080/07853890.2021.1988696.</cite> [<a href="https://doi.org/10.1080/07853890.2021.1988696" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8525987/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34658264/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Ann.%20Med.&amp;title=Hereditary%20transthyretin-related%20amyloidosis%20is%20frequent%20in%20polyneuropathy%20and%20cardiomyopathy%20of%20no%20obvious%20aetiology&amp;author=V.%20Skrahina&amp;author=U.%20Grittner&amp;author=C.%20Beetz&amp;author=T.%20Skripuletz&amp;author=M.%20Juenemann&amp;volume=53&amp;publication_year=2021&amp;pages=1787-1796&amp;pmid=34658264&amp;doi=10.1080/07853890.2021.1988696&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B9-jcm-13-06197">
<span class="label">9.</span><cite>Yeomans K.A., Golder P.A. The Guttman-Kaiser Criterion as a Predictor of the Number of Common Factors. Statistician. 1982;31:221. doi: 10.2307/2987988.</cite> [<a href="https://doi.org/10.2307/2987988" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Statistician&amp;title=The%20Guttman-Kaiser%20Criterion%20as%20a%20Predictor%20of%20the%20Number%20of%20Common%20Factors&amp;author=K.A.%20Yeomans&amp;author=P.A.%20Golder&amp;volume=31&amp;publication_year=1982&amp;pages=221&amp;doi=10.2307/2987988&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B10-jcm-13-06197">
<span class="label">10.</span><cite>Viswanathan S.K., Sanders H.K., McNamara J.W., Jagadeesan A., Jahangir A., Tajik A.J., Sadayappan S. Hypertrophic cardiomyopathy clinical phenotype is independent of gene mutation and mutation dosage. PLoS ONE. 2017;12:e0187948.  doi: 10.1371/journal.pone.0187948.</cite> [<a href="https://doi.org/10.1371/journal.pone.0187948" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5679632/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29121657/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20ONE&amp;title=Hypertrophic%20cardiomyopathy%20clinical%20phenotype%20is%20independent%20of%20gene%20mutation%20and%20mutation%20dosage&amp;author=S.K.%20Viswanathan&amp;author=H.K.%20Sanders&amp;author=J.W.%20McNamara&amp;author=A.%20Jagadeesan&amp;author=A.%20Jahangir&amp;volume=12&amp;publication_year=2017&amp;pages=e0187948&amp;pmid=29121657&amp;doi=10.1371/journal.pone.0187948&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B11-jcm-13-06197">
<span class="label">11.</span><cite>Familial Amyloidotic Polyneuropathy and Other Transthyretin Related Disorders. 2nd International Symposium. Skelleftea, Sweden, June 1–3, 1992. Abstracts. J. Rheumatol. 1993;20:173–198.</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/8095073/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Rheumatol.&amp;title=Familial%20Amyloidotic%20Polyneuropathy%20and%20Other%20Transthyretin%20Related%20Disorders.%202nd%20International%20Symposium.%20Skelleftea,%20Sweden,%20June%201%E2%80%933,%201992.%20Abstracts&amp;volume=20&amp;publication_year=1993&amp;pages=173-198&amp;pmid=8095073&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B12-jcm-13-06197">
<span class="label">12.</span><cite>Damy T., Kristen A.V., Suhr O.B., Maurer M.S., Planté-Bordeneuve V., Yu C.R., Ong M.L., Coelho T., Rapezzi C., Thaos Investigators  Transthyretin cardiac amyloidosis in continental Western Europe: An insight through the Transthyretin Amyloidosis Outcomes Survey (THAOS) Eur. Heart J. 2022;43:391–400. doi: 10.1093/eurheartj/ehz173.</cite> [<a href="https://doi.org/10.1093/eurheartj/ehz173" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8825236/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30938420/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur.%20Heart%20J.&amp;title=Transthyretin%20cardiac%20amyloidosis%20in%20continental%20Western%20Europe:%20An%20insight%20through%20the%20Transthyretin%20Amyloidosis%20Outcomes%20Survey%20(THAOS)&amp;author=T.%20Damy&amp;author=A.V.%20Kristen&amp;author=O.B.%20Suhr&amp;author=M.S.%20Maurer&amp;author=V.%20Plant%C3%A9-Bordeneuve&amp;volume=43&amp;publication_year=2022&amp;pages=391-400&amp;pmid=30938420&amp;doi=10.1093/eurheartj/ehz173&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B13-jcm-13-06197">
<span class="label">13.</span><cite>Ammirati E., AbouEzzeddine O.F. Transthyretin amyloidosis in Western Europe: A snapshot from the THAOS registry and a call for further perspectives. Eur. Heart J. 2019;43:401–404. doi: 10.1093/eurheartj/ehz205.</cite> [<a href="https://doi.org/10.1093/eurheartj/ehz205" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31006018/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur.%20Heart%20J.&amp;title=Transthyretin%20amyloidosis%20in%20Western%20Europe:%20A%20snapshot%20from%20the%20THAOS%20registry%20and%20a%20call%20for%20further%20perspectives&amp;author=E.%20Ammirati&amp;author=O.F.%20AbouEzzeddine&amp;volume=43&amp;publication_year=2019&amp;pages=401-404&amp;pmid=31006018&amp;doi=10.1093/eurheartj/ehz205&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B14-jcm-13-06197">
<span class="label">14.</span><cite>Stangou A.J., Hawkins P.N., Heaton N.D., Rela M., Monaghan M., Nihoyannopoulos P., O’Grady J., Pepys M.B., Williams R. Progressive cardiac amyloidosis following liver transplantation for familial amyloid polyneuropathy: Implications for amyloid fibrillogenesis. Transplantation. 1998;66:229–233. doi: 10.1097/00007890-199807270-00016.</cite> [<a href="https://doi.org/10.1097/00007890-199807270-00016" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9701270/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Transplantation&amp;title=Progressive%20cardiac%20amyloidosis%20following%20liver%20transplantation%20for%20familial%20amyloid%20polyneuropathy:%20Implications%20for%20amyloid%20fibrillogenesis&amp;author=A.J.%20Stangou&amp;author=P.N.%20Hawkins&amp;author=N.D.%20Heaton&amp;author=M.%20Rela&amp;author=M.%20Monaghan&amp;volume=66&amp;publication_year=1998&amp;pages=229-233&amp;pmid=9701270&amp;doi=10.1097/00007890-199807270-00016&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B15-jcm-13-06197">
<span class="label">15.</span><cite>Wixner J., Mundayat R., Karayal O.N., Anan I., Karling P., Suhr O.B., Investigators T. THAOS: Gastrointestinal manifestations of transthyretin amyloidosis—Common complications of a rare disease. Orphanet J. Rare Dis. 2014;9:61. doi: 10.1186/1750-1172-9-61.</cite> [<a href="https://doi.org/10.1186/1750-1172-9-61" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4005902/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24767411/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Orphanet%20J.%20Rare%20Dis.&amp;title=THAOS:%20Gastrointestinal%20manifestations%20of%20transthyretin%20amyloidosis%E2%80%94Common%20complications%20of%20a%20rare%20disease&amp;author=J.%20Wixner&amp;author=R.%20Mundayat&amp;author=O.N.%20Karayal&amp;author=I.%20Anan&amp;author=P.%20Karling&amp;volume=9&amp;publication_year=2014&amp;pages=61&amp;pmid=24767411&amp;doi=10.1186/1750-1172-9-61&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B16-jcm-13-06197">
<span class="label">16.</span><cite>Suhr O., Danielsson A., Holmgren G., Steen L. Malnutrition and gastrointestinal dysfunction as prognostic factors for survival in familial amyloidotic polyneuropathy. J. Intern. Med. 1994;235:479–485. doi: 10.1111/j.1365-2796.1994.tb01106.x.</cite> [<a href="https://doi.org/10.1111/j.1365-2796.1994.tb01106.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/8182405/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Intern.%20Med.&amp;title=Malnutrition%20and%20gastrointestinal%20dysfunction%20as%20prognostic%20factors%20for%20survival%20in%20familial%20amyloidotic%20polyneuropathy&amp;author=O.%20Suhr&amp;author=A.%20Danielsson&amp;author=G.%20Holmgren&amp;author=L.%20Steen&amp;volume=235&amp;publication_year=1994&amp;pages=479-485&amp;pmid=8182405&amp;doi=10.1111/j.1365-2796.1994.tb01106.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B17-jcm-13-06197">
<span class="label">17.</span><cite>Dahiya D.S., Kichloo A., Singh J., Albosta M., Wani F. Gastrointestinal amyloidosis: A focused review. World J. Gastrointest. Endosc. 2021;13:1–12. doi: 10.4253/wjge.v13.i1.1.</cite> [<a href="https://doi.org/10.4253/wjge.v13.i1.1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7809597/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33520102/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=World%20J.%20Gastrointest.%20Endosc.&amp;title=Gastrointestinal%20amyloidosis:%20A%20focused%20review&amp;author=D.S.%20Dahiya&amp;author=A.%20Kichloo&amp;author=J.%20Singh&amp;author=M.%20Albosta&amp;author=F.%20Wani&amp;volume=13&amp;publication_year=2021&amp;pages=1-12&amp;pmid=33520102&amp;doi=10.4253/wjge.v13.i1.1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B18-jcm-13-06197">
<span class="label">18.</span><cite>Ioannou A., Patel R.K., Razvi Y., Porcari A., Sinagra G., Venneri L., Bandera F., Masi A., Williams G.E., O’beara S., et al.  Impact of Earlier Diagnosis in Cardiac ATTR Amyloidosis Over the Course of 20 Years. Circulation. 2022;146:1657–1670. doi: 10.1161/CIRCULATIONAHA.122.060852.</cite> [<a href="https://doi.org/10.1161/CIRCULATIONAHA.122.060852" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9698091/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36325894/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Circulation&amp;title=Impact%20of%20Earlier%20Diagnosis%20in%20Cardiac%20ATTR%20Amyloidosis%20Over%20the%20Course%20of%2020%20Years&amp;author=A.%20Ioannou&amp;author=R.K.%20Patel&amp;author=Y.%20Razvi&amp;author=A.%20Porcari&amp;author=G.%20Sinagra&amp;volume=146&amp;publication_year=2022&amp;pages=1657-1670&amp;pmid=36325894&amp;doi=10.1161/CIRCULATIONAHA.122.060852&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B19-jcm-13-06197">
<span class="label">19.</span><cite>Monte I.P., Faro D.C., Trimarchi G., de Gaetano F., Campisi M., Losi V., Teresi L., Di Bella G., Tamburino C., de Gregorio C. Left Atrial Strain Imaging by Speckle Tracking Echocardiography: The Supportive Diagnostic Value in Cardiac Amyloidosis and Hypertrophic Cardiomyopathy. J. Cardiovasc. Dev. Dis. 2023;10:261.  doi: 10.3390/jcdd10060261.</cite> [<a href="https://doi.org/10.3390/jcdd10060261" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10299603/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37367426/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Cardiovasc.%20Dev.%20Dis.&amp;title=Left%20Atrial%20Strain%20Imaging%20by%20Speckle%20Tracking%20Echocardiography:%20The%20Supportive%20Diagnostic%20Value%20in%20Cardiac%20Amyloidosis%20and%20Hypertrophic%20Cardiomyopathy&amp;author=I.P.%20Monte&amp;author=D.C.%20Faro&amp;author=G.%20Trimarchi&amp;author=F.%20de%20Gaetano&amp;author=M.%20Campisi&amp;volume=10&amp;publication_year=2023&amp;pages=261&amp;pmid=37367426&amp;doi=10.3390/jcdd10060261&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B20-jcm-13-06197">
<span class="label">20.</span><cite>de Gregorio C., Trimarchi G., Faro D.C., Poleggi C., Teresi L., De Gaetano F., Zito C., Lofrumento F., Koniari I., Licordari R., et al.  Systemic Vascular Resistance and Myocardial Work Analysis in Hypertrophic Cardiomyopathy and Transthyretin Cardiac Amyloidosis with Preserved Left Ventricular Ejection Fraction. J. Clin. Med. 2024;13:1671.  doi: 10.3390/jcm13061671.</cite> [<a href="https://doi.org/10.3390/jcm13061671" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10970938/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38541896/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Clin.%20Med.&amp;title=Systemic%20Vascular%20Resistance%20and%20Myocardial%20Work%20Analysis%20in%20Hypertrophic%20Cardiomyopathy%20and%20Transthyretin%20Cardiac%20Amyloidosis%20with%20Preserved%20Left%20Ventricular%20Ejection%20Fraction&amp;author=C.%20de%20Gregorio&amp;author=G.%20Trimarchi&amp;author=D.C.%20Faro&amp;author=C.%20Poleggi&amp;author=L.%20Teresi&amp;volume=13&amp;publication_year=2024&amp;pages=1671&amp;pmid=38541896&amp;doi=10.3390/jcm13061671&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B21-jcm-13-06197">
<span class="label">21.</span><cite>Licordari R., Trimarchi G., Teresi L., Restelli D., Lofrumento F., Perna A., Campisi M., de Gregorio C., Grimaldi P., Calabrò D., et al.  Cardiac Magnetic Resonance in HCM Phenocopies: From Diagnosis to Risk Stratification and Therapeutic Management. J. Clin. Med. 2023;12:3481.  doi: 10.3390/jcm12103481.</cite> [<a href="https://doi.org/10.3390/jcm12103481" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10218866/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37240587/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Clin.%20Med.&amp;title=Cardiac%20Magnetic%20Resonance%20in%20HCM%20Phenocopies:%20From%20Diagnosis%20to%20Risk%20Stratification%20and%20Therapeutic%20Management&amp;author=R.%20Licordari&amp;author=G.%20Trimarchi&amp;author=L.%20Teresi&amp;author=D.%20Restelli&amp;author=F.%20Lofrumento&amp;volume=12&amp;publication_year=2023&amp;pages=3481&amp;pmid=37240587&amp;doi=10.3390/jcm12103481&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B22-jcm-13-06197">
<span class="label">22.</span><cite>Wang J., Chen H., Tang Z., Zhang J., Xu Y., Wan K., Hussain K., Gkoutos G.V., Han Y., Chen Y. Tafamidis treatment in patients with transthyretin amyloid cardiomyopathy: A systematic review and meta-analysis. eClinicalMedicine. 2023;63:102172. doi: 10.1016/j.eclinm.2023.102172.</cite> [<a href="https://doi.org/10.1016/j.eclinm.2023.102172" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10474377/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37662524/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=eClinicalMedicine&amp;title=Tafamidis%20treatment%20in%20patients%20with%20transthyretin%20amyloid%20cardiomyopathy:%20A%20systematic%20review%20and%20meta-analysis&amp;author=J.%20Wang&amp;author=H.%20Chen&amp;author=Z.%20Tang&amp;author=J.%20Zhang&amp;author=Y.%20Xu&amp;volume=63&amp;publication_year=2023&amp;pages=102172&amp;pmid=37662524&amp;doi=10.1016/j.eclinm.2023.102172&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/11508262/bin/jcm-13-06197-s001.zip" data-ga-action="click_feat_suppl" class="usa-link">jcm-13-06197-s001.zip</a><sup> (558.7KB, zip) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>Data are available upon reasonable request. All data relevant to the study are included in the article or in the <a href="#app1-jcm-13-06197" class="usa-link">Supplementary Information</a>. The datasets supporting the current study are not public, due to data privacy laws for patients. Some data may be available upon request to the corresponding author.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Journal of Clinical Medicine are provided here courtesy of <strong>Multidisciplinary Digital Publishing Institute  (MDPI)</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.3390/jcm13206197"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/jcm-13-06197.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (855.6 KB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/11508262/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/11508262/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC11508262%2F%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC11508262/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC11508262/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC11508262/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/39458146/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC11508262/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/39458146/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC11508262/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/11508262/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="HXoqPoko0YqwddH0SrMOqIyt27yzth54IGb7i9IAXkF2xG0l6FRuem03NVO96RMI">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
